WO2023033414A1 - Liposomal cosmetic composition with excellent capture performance of effective component - Google Patents

Liposomal cosmetic composition with excellent capture performance of effective component Download PDF

Info

Publication number
WO2023033414A1
WO2023033414A1 PCT/KR2022/012309 KR2022012309W WO2023033414A1 WO 2023033414 A1 WO2023033414 A1 WO 2023033414A1 KR 2022012309 W KR2022012309 W KR 2022012309W WO 2023033414 A1 WO2023033414 A1 WO 2023033414A1
Authority
WO
WIPO (PCT)
Prior art keywords
cosmetic composition
liposome
weight
skin
carbon material
Prior art date
Application number
PCT/KR2022/012309
Other languages
French (fr)
Korean (ko)
Inventor
하지훈
박정미
최형
한상근
Original Assignee
한국콜마주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 한국콜마주식회사 filed Critical 한국콜마주식회사
Publication of WO2023033414A1 publication Critical patent/WO2023033414A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14Liposomes; Vesicles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin

Definitions

  • It relates to a liposome cosmetic composition with excellent trapping ability of active ingredients.
  • the skin is composed of the epidermis, dermis, and subcutaneous fat, among which the epidermis is composed of a basal layer, a spinous layer, a granular layer, and a stratum corneum.
  • the stratum corneum has a structure in which keratinocytes are stacked in multiple layers, and a lipid component exists in the empty space between keratinocytes.
  • transdermal absorption route is more effective when penetrating the lipid component located between the keratinocytes of the skin rather than directly penetrating the keratinocytes of the skin.
  • liposomes improve the stability of cosmetic compositions by collecting and containing ingredients that are poorly soluble or difficult to be stably supported in cosmetic composition formulations while increasing the skin penetration rate of active ingredients. development is becoming more active.
  • Korean Patent Registration No. 10-0758960 discloses a cosmetic composition containing a nanoliposome-stabilized persimmon fruit extract as a skin improvement component.
  • a liposome cosmetic composition that includes a plurality of active ingredients to exhibit various functions at the same time, has excellent trapping power of active ingredients, and has excellent stability.
  • One aspect provides a cosmetic composition containing liposomes capable of implementing various functions including a plurality of active ingredients at the same time, while having excellent trapping power of active ingredients, stability of liposomes, and skin penetration, which can realize improved skin improvement effects. is to do
  • Another aspect is to provide an external preparation for skin containing the liposome.
  • the object of the present invention is not limited to the technical problem as described above, and another technical problem may be derived from the following description.
  • One aspect is a physiologically active substance;
  • the cosmetic composition containing the liposome contains 0.0001 to 1.0% by weight of the bioactive material, 0.001 to 3.0% by weight of the carbon material, 0.001 to 1.0% by weight of the surfactant and 0.2 to 5% by weight of the lipid based on the total weight of the cosmetic composition.
  • the cosmetic composition including the liposome may include the bioactive material and the carbon material in a weight ratio of 0.01 to 1:1.
  • the bioactive material may include a whitening component, an antioxidant component, an anti-wrinkle component, a moisturizing component, and an anti-inflammatory component. It may include any one or more selected from the group consisting of components, skin regeneration components, and skin aging inhibitory components.
  • the whitening component may include at least one selected from the group consisting of niacinamide, adenosine, and retinoid-based components.
  • the surfactant is polyglyceryl-3methylglucose distearate, glucolipid, lysolecitin, sorbitan stearate, glyceryl oleate, glyceryl stearate, polyoxyalkylene alkyl ether, polyoxyalkylene fatty acid ester, Alkyl poly glucoside, sodium lauryl ether sulfate, stearyl trimethyl ammonium chloride, alkyl polyglyceryl ether, stearyl trimethyl ammonium chloride, lauryl trimethyl ammonium chloride, distearyl dimethyl-ammonium chloride, poly(N,N'-dimethyl -3,5-methylene piperidinium) chloride, cetylpyridinium chloride, alkyltetraammonium salt, alkyldimethylbenzylammonium salt, alkylisoquinolinium salt, dialkyl-morpholinium salt, polyamine fatty acid derivative, amyl alcohol
  • the lipid is soybean lecithin, egg yolk lecithin, hydrogenated lecithin, hydrogenated lysolecithin, hydrooxylated lecithin, tocopherol, tocopheryl acetate, aluminum/magnesium hydroxide stearate, pentaerythrityltetradi-t- It may include at least one selected from the group consisting of butyl hydroxyhydrocinnamate and capric triglyceride.
  • the cosmetic composition containing the liposome may further include at least one selected from the group consisting of polyol, oil, preservative and purified water.
  • Another aspect is to provide a composition for external application for skin containing the liposome.
  • composition of one aspect is excellent in trapping active ingredients including a whitening component including niacinamide and a carbon material including at least one selected from the group consisting of fullerene and fullerol, and the stability and skin penetration of liposomes are remarkably good. can be excellent
  • composition of the present embodiment can have excellent skin improvement effects by simultaneously implementing various functions such as whitening and wrinkle improvement.
  • a and/or B means A or B, or A and B.
  • One aspect provides a cosmetic composition comprising a liposome having excellent trapping ability of an active ingredient.
  • a physiologically active substance A carbon material containing at least one selected from the group consisting of fullerene and fullerol; Surfactants; And lipids; It provides a cosmetic composition comprising a liposome containing.
  • the liposome may be a spherical vesicle of a lipid double layer including a lipid and a surfactant, and a carbon material or a physiologically active material may be supported inside the spherical vesicle.
  • the diameter of the liposome is 5 to 1,500 nm, for example, 5 to 1,000 nm, 10 to 1,500 nm, 10 to 1,000 nm, 10 to 800 nm, 10 to 500 nm, 5 to 500 nm, 5 to 300 nm, 10 to 300 nm, 5 to 200 nm, 5 to 100 nm, or 10 to 100 nm.
  • the cosmetic composition containing liposomes of one embodiment can implement various effects such as whitening and wrinkle improvement by including a plurality of active ingredients such as physiologically active substances and carbon materials.
  • the cosmetic composition containing the liposome of one embodiment has excellent trapping ability of active ingredients, excellent stability of the liposome itself, and good skin penetration rate, so that the skin improvement effect may be excellent.
  • a cosmetic composition containing a liposome of one embodiment may include a physiologically active substance, for example, a whitening component, an antioxidant component, a wrinkle improvement component, a moisturizing component, an anti-inflammatory component, a skin regeneration component, or a skin aging inhibitory component.
  • a physiologically active substance for example, a whitening component, an antioxidant component, a wrinkle improvement component, a moisturizing component, an anti-inflammatory component, a skin regeneration component, or a skin aging inhibitory component.
  • physiologically active substances means substances capable of imparting useful activities to a subject, for example, skin regeneration, skin anti-aging, skin wrinkles, skin whitening, skin moisturizing, and the like.
  • the bioactive material may be supported in the liposome.
  • the whitening component of one embodiment may include all known components capable of implementing a whitening effect.
  • the whitening component of one embodiment may include one or more selected from the group consisting of niacinamide, adenosine, and retinoid-based components. More specifically, the whitening component of one embodiment may include niacinamide, but is not limited thereto.
  • the retinoid-based component means a derivative of vitamin A, and for example, retinol, retinal, retinoic acid, retinyl acetate, retinyl propionate ( retinyl propionate), retinyl linoleate, and retinyl palmitate.
  • the cosmetic composition containing the liposome of one embodiment may include 0.0001 to 1.0% by weight, specifically 0.0003 to 0.1% by weight of the physiologically active material based on the total weight of the cosmetic composition.
  • a cosmetic composition containing liposomes of one embodiment includes a physiologically active substance, but when the physiologically active substance is included in an amount of 0.0001 to 1.0% by weight, the liposome of an appropriate size maintains a stable state for a long period of time while maintaining active ingredient capture rate and skin penetration rate And the skin improvement effect may be more excellent.
  • the skin improvement effect is greater than when the cosmetic composition contains 0.0001 to 1.0% by weight of the physiologically active material. may be lowered
  • the stability of the liposome is higher than when the cosmetic composition contains 0.0001 to 1.0% by weight of the physiologically active material. decrease, and the capture rate and skin penetration rate of active ingredients are reduced, and the degree of improvement of the skin improvement effect may be insignificant.
  • a cosmetic composition comprising a liposome of one embodiment includes a carbon material.
  • the cosmetic composition containing liposomes of one embodiment may include a carbon material containing at least one selected from the group consisting of fullerene and fullerol.
  • the fullerene refers to a molecule in which carbon atoms are arranged in a spherical, ellipsoidal, or cylindrical shape, and generally means a spherical carbon material, and is known to have antioxidant, whitening, and anti-wrinkle effects.
  • the fullerol is obtained by introducing a hydroxyl group into fullerene, and is also called hydroxylated fullerene.
  • the carbon material of one embodiment may include each of the above fullerenes or fullerols alone.
  • the carbon material of one embodiment may include both the fullerene and the fullerol.
  • the capture rate of the active ingredient of the liposome is better than when the fullerene or the fullerol is included alone, and the stability and skin penetration rate of the liposome are improved. It is excellent, and the skin improvement effect can be improved.
  • the carbon material of one embodiment includes both the fullerene and the fullerol, and may include the fullerene and the fullerol in a weight ratio of 0.1 to 10:1.
  • the liposome has a good capture rate of active ingredients, and the liposome has excellent stability and skin penetration, so that the skin improvement effect is obtained. can be significantly improved.
  • the carbon material of one embodiment includes both the fullerene and the fullerol, and may include the fullerene and the fullerol in a weight ratio of 1 to 3:1.
  • the liposome has a good capture rate of active ingredients, excellent liposome stability and skin penetration, and has a skin improvement effect. can be significantly better.
  • the cosmetic composition containing the liposome of one embodiment may include 0.001 to 3.0% by weight, specifically 0.01 to 2% by weight of the carbon material based on the total weight of the composition.
  • the cosmetic composition containing liposomes of one embodiment includes carbon materials in an amount of 0.001 to 3.0% by weight based on the total weight, the active ingredient capture rate and skin penetration rate while maintaining a stable state for a long period of time while keeping the liposomes of an appropriate size stable. And the skin improvement effect may be more excellent.
  • the cosmetic composition containing the liposome of one embodiment contains less than 0.001% by weight of the carbon material based on the total weight, the capture rate of the active ingredient and The stability and skin permeation rate of liposomes are lowered, so the degree of improvement in the skin improvement effect may be insignificant.
  • the cosmetic composition containing the liposome of one embodiment contains more than 3.0% by weight of the carbon component based on the total weight, the stability of the liposome is lowered than when the carbon material is included in 0.001 to 3.0% by weight. , the capture rate and skin penetration rate of active ingredients are lowered, so the degree of improvement in the skin improvement effect may be insignificant.
  • the cosmetic composition containing liposomes of one embodiment may include the bioactive material and the carbon material in a weight ratio of 0.01 to 1: 1, in which case, liposomes of an appropriate size are formed and can maintain a stable state for a long period of time.
  • the active ingredient capture rate and skin penetration rate of liposomes are excellent, so the skin can be effectively improved.
  • the bioactive material and the carbon material are not included in a weight ratio of 0.01 to 1: 1, the stability of the liposome is lowered and the skin improvement effect is lowered due to the remaining physiologically active material that is not captured in the liposome. There may be a problem.
  • a cosmetic composition comprising the liposome of one embodiment includes a surfactant.
  • the cosmetic composition containing the liposome of one embodiment is polyglyceryl-3methylglucose distearate, glucolipid, lysolecitin, sorbitan stearate, glyceryl oleate, glyceryl stearate, polyoxyalkylene alkyl ether, poly Oxyalkylene fatty acid ester, alkyl polyglucoside, sodium lauryl ether sulfate, stearyl trimethyl ammonium chloride, alkyl polyglyceryl ether, stearyl trimethyl ammonium chloride, lauryl trimethyl ammonium chloride, distearyl dimethyl-ammonium chloride, poly( N,N′-dimethyl-3,5-methylenepiperidinium) chloride, cetylpyridinium chloride, alkyltetraammonium salt, alkyldimethylbenzylammonium salt, alkylisoquinolinium salt, dialkyl-morpholinium salt, polyamine fatty
  • the surfactant of one embodiment may include polyglyceryl-3methylglucose distearate.
  • the polyglyceryl-3methylglucose distearate is an edge activator component, so that the active ingredient can easily enter the liposome to increase the capture rate of the active ingredient, while increasing the elasticity of the liposome to realize excellent skin permeability. can do.
  • the cosmetic composition containing the liposome of one embodiment may include 0.001 to 1.0% by weight, specifically 0.01 to 0.5% by weight of a surfactant based on the total weight of the cosmetic composition.
  • a surfactant in an amount of 0.001 to 1.0% by weight based on the total weight, the active ingredient capture rate and skin penetration rate while maintaining a stable state for a long period of time while maintaining a stable state of liposomes of appropriate size And the skin improvement effect may be more excellent.
  • the cosmetic composition containing the liposome of one embodiment contains less than 0.001% by weight of the surfactant based on the total weight, the capture rate of the active ingredient and The stability and skin permeation rate of liposomes are lowered, so the degree of improvement in the skin improvement effect may be insignificant.
  • the cosmetic composition containing the liposome of one embodiment contains more than 1.0% by weight of the surfactant based on the total weight, the stability of the liposome is lowered than when the surfactant is included in 0.001 to 1.0% by weight. , the capture rate and skin penetration rate of active ingredients are lowered, so the degree of improvement in the skin improvement effect may be insignificant.
  • a cosmetic composition containing a liposome of one embodiment includes a lipid.
  • the cosmetic composition comprising the liposome of one embodiment is soybean lecithin, egg yolk lecithin, hydrogenated lecithin, hydrogenated lysolecithin, hydroxylated lecithin, tocopherol, tocopheryl acetate, aluminum/magnesium hydroxide stearate, pentagram
  • a lipid containing at least one selected from the group consisting of erythrityltetra-di-t-butylhydroxyhydrocinnamate and capric triglyceride may be included.
  • the cosmetic composition containing the liposome of one embodiment may be a phospholipid, wherein the phospholipid is selected from the group consisting of soybean lecithin, egg yolk lecithin, hydrogenated lecithin, hydrogenated lysolecithin and hydroxylated lecithin may contain one or more.
  • the cosmetic composition containing the liposome of one embodiment may include 0.2 to 5.0% by weight of lipid, specifically 0.2 to 1.0% by weight based on the total weight of the composition.
  • the cosmetic composition containing liposomes of one embodiment includes lipids in an amount of 0.2 to 5.0% by weight based on the total weight, the liposomes of appropriate size maintain a stable state for a long period of time while maintaining active ingredient capture rate, skin penetration rate, and The skin improvement effect may be more excellent.
  • the cosmetic composition containing the liposome of one embodiment contains less than 0.2% by weight of the lipid based on the total weight, than the case where the lipid is contained in 0.2 to 5.0% by weight, the capture rate of the active ingredient and the Stability and skin penetration rate are lowered, and the degree of improvement of the skin improvement effect may be insignificant.
  • the cosmetic composition containing the liposome of one embodiment contains more than 5.0% by weight of lipid based on the total weight, the stability of the liposome is lowered than when it contains 0.2 to 5.0% by weight of the lipid, and the effective The collection rate and skin penetration rate of components are lowered, so the degree of improvement in the skin improvement effect may be insignificant.
  • the cosmetic composition comprising the liposome of one embodiment may further include a polyol.
  • the cosmetic composition containing the liposome of one embodiment may include 0.01 to 60.0% by weight of polyol, specifically 1 to 40.0% by weight, but is not limited thereto.
  • the polyol of one embodiment may include all known polyols.
  • the polyol may include butylene glycol, glycerin, glycerol, propanol, 1,2hexanediol, 1,3-butylene glycol, and propylene glycol. It may include one or more selected from the group consisting of lycol, dipropylene glycol, isoprene glycol, sorbitol, xylitol, erythritol, fructose, lactose, mannitol, glucose, sucrose, maltose, and maltitol, but is not limited thereto. don't
  • the cosmetic composition comprising the liposome of one embodiment may further include oil.
  • the cosmetic composition containing the liposome of one embodiment may include 0.0001 to 10% by weight of oil, specifically 0.001 to 5% by weight of oil, but is not limited thereto.
  • the oil of one embodiment may include all known oils, for example, mango butter oil, shea butter oil, cocoa seed butter oil, macadamia nut oil, olive oil, meadowfoam seed oil, refined grape seed oil, rosehip Oil, safflower oil, peach seed oil, sunflower seed oil, macadamia seed oil, caprylyl carbonate, squalane, neopentyl glycol diheptanoate, tocopheryl acetate, trioctanoin, C12-15 alkylethylhexane Noate, Octyldodecyl Myristate, Tricaprylin, Octyldodecyl Stearoyl Stearate, Bis-Hydroxyethoxypropyl Dimethicone, Caprylic/Capric Triglyceride, Isotridecyl Isononanoate, Polyglyceryl-2triisostearate, Diisostearyl Maleate, Dipentaerythrite Fatty Acid
  • the cosmetic composition comprising the liposome of one embodiment may further include a preservative.
  • the cosmetic composition containing the liposome of one embodiment may include a preservative at 0.1 to 10% by weight, specifically 0.5 to 2% by weight, but is not limited thereto.
  • Preservatives of one embodiment may include all known preservatives, and may include, for example, at least one selected from the group consisting of 1,2-hexanediol and pentylene glycol, but is not limited thereto.
  • the cosmetic composition of one embodiment may further include excipients or additives necessary for formulation of each formulation in addition to the above components.
  • the excipients or additives include surfactants, emulsifiers, emulsifiers, silicone polymers, pigments, colorants, fragrances, preservatives, bactericides, oxidation stabilizers, organic solvents, softeners, antioxidants, free radical destroyers, opacifiers, As a stabilizer, emollient, antifoam, moisturizer, vitamin, insect repellent, preservative, anti-inflammatory, filler, polymer, propellant, alkalizing agent, acidifying agent, colorant, thickening agent, skin conditioning agent, whitening agent, antioxidant, anti-wrinkle agent and solubilizing agent It may include one or more selected from the group consisting of, but is not limited thereto.
  • the cosmetic composition of one embodiment consists of softening lotion, nutrient lotion, astringent lotion, toner, lotion, essence, serum, cream, massage cream, pack, makeup base, BB cream, foundation, powder, cleansing foam, cleansing cream and cleansing water It may be one formulation selected from the group, but is not limited thereto.
  • Another aspect is a bioactive substance;
  • bioactive material carbon material, surfactant, lipid and liposome are as described above.
  • the external skin preparation may be a cream, gel, ointment, skin emulsifier, skin suspension, transdermal delivery patch, drug-containing bandage, lotion, or a combination thereof.
  • the external skin preparation is a component usually used in external preparations for skin such as cosmetics or pharmaceuticals, for example, water-based components, oil-based components, powder components, alcohols, moisturizers, thickeners, ultraviolet absorbers, whitening agents, preservatives, antioxidants, surfactants, and fragrances. , colorants, various skin nutrients, or combinations thereof and may be suitably blended as needed.
  • a liposome cosmetic composition was prepared by mixing the whitening component, carbon material, surfactant, lipid, polyol, oil, preservative and purified water according to Table 1 [unit: weight%].
  • niacinamide was used as a whitening component
  • polyglyceryl-3methylglucose distearate (trade name: TEGOCARE 450) was used as a surfactant
  • phospholipid was used as a lipid.
  • Example 1 Example 1, Example 2 and Comparative Example 1 whitening ingredient 0.04 carbon material fullerene fuller roll Surfactants 0.1 lipids 1.0 polyol 40 oil 0.001 antiseptic 0.01 Purified water to. 100
  • Example 1 Example 2 Comparative Example 1 whitening ingredients One 0.01 1.2 carbon material One One One
  • the whitening component, carbon material, surfactant, lipid, polyol, oil, preservative and purified water were mixed according to Table 3 [unit: weight%], except that the liposome composition was prepared, and carried out in the same manner as in Example 1. did
  • Example 1 Example 3
  • Example 4 Example 5
  • Example 6 Example 7 fullerene 1.5 - 0.11 0.67 9 One floral One One One One One -
  • Example 5 looking at Example 1, Example 2 and Comparative Example 1, when the liposomal cosmetic composition includes a whitening component and a carbon material in a weight ratio of 0.01 to 1: 1, the whitening component remaining without being captured in the liposome It can be seen that the collection rate of the whitening component is 100%, which is very excellent.
  • Comparative Example 1 since the whitening component is included in an excessive amount compared to the carbon material, unencapsulated niacinamide remains, and thus, unencapsulated niacinamide may not be effectively absorbed into the skin and may not be economical.
  • the niacinamide component may be exposed to the outside and cause problems such as discoloration or oxidation, and may cause skin irritation.
  • the collection rate is as high as 88% or more even when the carbon material includes fullerene or fullerol alone, and preferably the carbon material is fullerene and fullerol. It can be seen that the collection rate is further improved to 92% or more when all of the fullerols are included. In particular, it can be seen that when the mixing ratio of fullerene and fullerol in the carbon material is 3:2, the whitening component capture rate is the best at 100%.
  • a liposome cosmetic composition was prepared by mixing the whitening component, carbon material, surfactant, lipid, polyol, oil, preservative and purified water according to Table 6 [unit: weight%].
  • niacinamide was used as a whitening component
  • polyglyceryl-3methylglucose distearate (trade name: TEGOCARE 450) was used as a surfactant
  • phospholipid was used as a lipid.
  • Example 8 Example 9 Example 10 whitening ingredient 0.01 0.01 0.01 carbon material fullerene 0.006 0.01 - fuller roll 0.004 - 0.01
  • Surfactants 0.1 0.1 0.1 lipids 1.0 1.0 1.0 1.0 polyol 40.0 40.0 40.0 oil 0.001 0.001 0.001 antiseptic 2.0 2.0 2.0 Purified water to. 100
  • the liposome cosmetic composition was prepared by mixing the whitening component, carbon material, surfactant, lipid, polyol, oil, preservative and purified water according to Table 7 [unit: weight%]. conducted.
  • Example 8 Example 11 Comparative Example 2 whitening ingredient 0.01 0.01 0.01 carbon material fullerene 0.006 0.006 0.006 fuller roll 0.004 0.004 0.004 Surfactants 0.1 0.1 0.1 lipids 1.0 1.3 0.16 polyol 40.0 40.0 40.0 oil 0.001 0.001 0.001 antiseptic 2.0 2.0 2.0 Purified water to. 100
  • the liposome cosmetic composition was prepared by mixing the whitening component, carbon material, surfactant, lipid, polyol, oil, preservative and purified water according to Table 8 [Unit:% by weight]. conducted.
  • Example 8 Comparative Example 3 Comparative Example 4 Comparative Example 5 whitening ingredient 0.01 0.01 0.01 0.01 0.01 carbon material fullerene 0.006 0.006 0.006 fuller roll 0.004 0.004 0.004 0.004 Surfactants 0.1 0.0002 - 2.0 lipids 0.2 0.2 0.2 0.5 polyol 40.0 40.0 40.0 40.0 oil 0.001 0.001 0.001 0.001 antiseptic 2.0 2.0 2.0 2.0 2.0 Purified water to. 100
  • the liposome cosmetic composition was prepared by mixing the whitening component, carbon material, surfactant, lipid, polyol, oil, preservative and purified water according to Table 9 [Unit:% by weight]. conducted.
  • Example 8 Comparative Example 6 Comparative Example 7 Comparative Example 8 Comparative Example 9 Comparative Example 10 Comparative Example 11 Comparative Example 12 whitening ingredient 0.01 0.01 - 0.01 - - 0.01 0.01 carbon material fullerene 0.006 - 0.006 - 0.006 - 0.01 - fuller roll 0.004 - 0.004 - 0.004 - - 0.01 Surfactants 0.1 0.1 0.1 0.1 0.1 - - lipids 1.0 1.0 1.0 - - 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
  • the particle size (unit: nm) and elasticity of the liposomes were evaluated.
  • the ability of the elastic liposome to pass through the artificial permeability barrier was measured using a mini extruder.
  • the amount of elastic liposome passing through a polycarbonate membrane having pores of 0.08 ⁇ m was measured, and the particle size of the liposome passing through it was measured. .
  • the elasticity of the elastic liposome membrane is proportional to the following formula.
  • '-' in Table 10 means a state in which it is difficult to measure the particle size itself due to the non-uniform and unstable state of the liposome.
  • the particle size is formed at an appropriate level and the elasticity value is excellent.
  • the stability of the liposome was evaluated according to the following items while observing for 4 weeks by measuring the particle size of the liposome every week according to Experimental Example 2 described above.
  • liposomes are stably and uniformly dispersed, and there is no precipitation of carbon materials, which means that excellent liposome stability can be realized.
  • the skin penetration rate was evaluated by performing a transdermal absorption diffusion experiment (Franz diffusion cell).
  • 'skin penetration rate (%) (niacinamide content measured in the skin / niacinamide content contained in the deposited cream) X 100 (%)', and the results are shown in the table 12.
  • a cosmetic composition in which 40% by weight of polyol, 2% by weight of preservative, and the remaining amount of purified water was mixed was used.
  • Example 12 Comparative Example 13 whitening ingredient 0.5 0.5 carbon material 0.5 0.5 Surfactants 0.1 - lipids 1.0 1.0 polyol 40.0 40.0 oil 0.001 0.001 antiseptic 2.0 2.0 Purified water to 100
  • Example 12 In the liposome cosmetic compositions of Example 12 and Comparative Example 13, the collection rate of carbon materials was evaluated, and the results are shown in Table 15 [Unit: %].
  • the remaining carbon material is increased without being trapped in the liposome. That is, when the present embodiment is not followed, as the carbon material is not effectively absorbed into the skin, the skin improvement effect may not be sufficient.
  • a liposome cosmetic composition in a stable state by being formed in an appropriate size while having excellent trapping power of whitening ingredients and carbon materials. Accordingly, the whitening and anti-wrinkle effect of the liposome cosmetic composition may be remarkably excellent.

Abstract

The present invention relates to a composition comprising liposomes containing: a biologically active material; a carbonaceous material including at least one selected from the group consisting of fullerene and fullerol; a surfactant; and a lipid, and provides a liposome-containing composition wherein the liposomes are superb in capture performance of effective components, stability, and dermal penetration, whereby the effective components bring about a remarkable improvement in skin whitening, wrinkle reduction, etc.

Description

유효 성분의 포집력이 우수한 리포좀 화장료 조성물Liposomal cosmetic composition with excellent trapping ability of active ingredients
유효 성분의 포집력이 우수한 리포좀 화장료 조성물에 관한 것이다.It relates to a liposome cosmetic composition with excellent trapping ability of active ingredients.
피부는 표피, 진피 및 피하 지방으로 구성되며, 그 중에서 표피는 기저층, 유극층, 과립층 및 각질층으로 이루어진다. 상기 각질층은 각질 세포가 여러 겹으로 쌓여있는 구조로 형성되며, 각질 세포 간의 빈 공간에는 지질 성분이 존재한다. The skin is composed of the epidermis, dermis, and subcutaneous fat, among which the epidermis is composed of a basal layer, a spinous layer, a granular layer, and a stratum corneum. The stratum corneum has a structure in which keratinocytes are stacked in multiple layers, and a lipid component exists in the empty space between keratinocytes.
이때, 경피 흡수 경로는 피부의 각질 세포를 직접적으로 투과하기 보다는 피부 각질 세포 사이에 위치하는 지질 성분을 투과할 때, 더욱 효과적인 것으로 보고되고 있어, 지질 성분을 주성분으로 하는 리포좀(Liposome)을 이용한 유효 성분의 피부 흡수 전달 시스템에 대한 관심이 증가되고 있다. At this time, it is reported that the transdermal absorption route is more effective when penetrating the lipid component located between the keratinocytes of the skin rather than directly penetrating the keratinocytes of the skin. There is increasing interest in skin absorption delivery systems for ingredients.
특히, 리포좀은 유효 성분의 피부 침투율을 높이면서도 난용성이거나 화장료 조성물 제형 내에 안정적으로 담지가 어려운 성분들을 포집하여 함유함으로써, 화장료 조성물의 안정성 또한 향상시킴에 따라, 최근에는 리포좀을 이용한 화장료 조성물에 대한 개발이 더욱 활발해지고 있다. In particular, liposomes improve the stability of cosmetic compositions by collecting and containing ingredients that are poorly soluble or difficult to be stably supported in cosmetic composition formulations while increasing the skin penetration rate of active ingredients. development is becoming more active.
일례로, 대한민국 등록특허 제10-0758960호에서는 피부 개선 성분으로서 나노리포좀으로 안정화시킨 감 열매 추출물을 함유하는 화장료 조성물에 대해 개시하고 있다. For example, Korean Patent Registration No. 10-0758960 discloses a cosmetic composition containing a nanoliposome-stabilized persimmon fruit extract as a skin improvement component.
한편, 상기 등록특허에 개시된 바와 같이, 특정 효과를 나타내는 유효 성분을 포집한 리포좀을 이용한 화장료 조성물에 대한 개발이 활발한 상황이나, 대부분 단일 기능을 나타내는 단일 성분을 포집하고 있을 뿐, 미백, 주름 개선, 보습 등 다양한 기능을 동시에 나타내도록 복수의 유효 성분을 포함하는 리포좀 화장료 조성물에 대한 개발은 다소 부족한 실정이다. On the other hand, as disclosed in the registered patent, development of cosmetic compositions using liposomes that capture active ingredients that exhibit specific effects is active, but most of them only capture a single ingredient that exhibits a single function, such as whitening, wrinkle improvement, Development of a liposome cosmetic composition containing a plurality of active ingredients to simultaneously exhibit various functions such as moisturizing is lacking.
또한, 대부분의 화장료 조성물은, 사용 방법에 따른 차이가 있으나, 평균적으로 상온 조건에서 적어도 1 달 이상 방치되는데, 리포좀 화장료 조성물의 경우, 일반 화장료 조성물 보다 안정성이 낮아, 시간이 지남에 따라, 리포좀의 입자 크기가 불균일해지거나, 리포좀 내에 포집된 성분이 석출되는 문제가 있었다. In addition, most cosmetic compositions, although there are differences depending on the method of use, are left on average at room temperature for at least one month. In the case of liposome cosmetic compositions, stability is lower than that of general cosmetic compositions, and over time, liposomes There was a problem that the particle size became non-uniform and components trapped in the liposome were precipitated.
이에 따라, 다양한 기능을 동시에 나타내도록 복수의 유효 성분을 포함하면서도 유효 성분의 포집력이 우수하고, 안정성이 우수한, 리포좀 화장료 조성물에 대한 개발이 요구되고 있다.Accordingly, there is a demand for the development of a liposome cosmetic composition that includes a plurality of active ingredients to exhibit various functions at the same time, has excellent trapping power of active ingredients, and has excellent stability.
일 양상은, 복수의 유효 성분을 포함하여 다양한 기능을 동시에 구현하면서도, 유효 성분의 포집력과 리포좀의 안정성 및 피부 침투력이 우수하여, 향상된 피부 개선 효과를 구현할 수 있는 리포좀을 포함하는 화장료 조성물을 제공하는 데에 있다.One aspect provides a cosmetic composition containing liposomes capable of implementing various functions including a plurality of active ingredients at the same time, while having excellent trapping power of active ingredients, stability of liposomes, and skin penetration, which can realize improved skin improvement effects. is to do
다른 양상은 상기 리포좀을 포함하는 피부외용제를 제공하는 데에 있다.Another aspect is to provide an external preparation for skin containing the liposome.
본 발명의 목적은 상기된 바와 같은 기술적 과제로 한정되지 않으며, 이하의 설명으로부터 또 다른 기술적 과제가 도출될 수 있다.The object of the present invention is not limited to the technical problem as described above, and another technical problem may be derived from the following description.
일 양상은 생리활성물질; 풀러렌(Fullerene) 및 풀러롤(Fullerol)로 이루어진 군에서 선택되는 하나 이상을 포함하는 탄소 물질; 계면활성제; 및 지질;을 포함하는 리포좀을 포함하는 화장료 조성물을 제공한다. One aspect is a physiologically active substance; A carbon material containing at least one selected from the group consisting of fullerene and fullerol; Surfactants; And lipids; It provides a cosmetic composition comprising a liposome containing.
상기 리포좀을 포함하는 화장료 조성물은 상기 화장료 조성물 총 중량 기준으로 상기 생리활성물질 0.0001 ~ 1.0 중량%, 상기 탄소 물질 0.001 ~ 3.0 중량%, 상기 계면활성제 0.001 ~ 1.0 중량% 및 상기 지질 0.2 ~ 5 중량%를 포함할 수 있다.The cosmetic composition containing the liposome contains 0.0001 to 1.0% by weight of the bioactive material, 0.001 to 3.0% by weight of the carbon material, 0.001 to 1.0% by weight of the surfactant and 0.2 to 5% by weight of the lipid based on the total weight of the cosmetic composition. can include
상기 리포좀을 포함하는 화장료 조성물은 상기 생리활성물질 및 상기 탄소 물질을 0.01 ~ 1 : 1 의 중량비로 포함할 수 있다.상기 생리활성물질은 미백 성분, 항산화 성분, 주름 개선 성분, 보습 성분, 항염증 성분, 피부재생 성분, 및 피부노화 억제 성분으로 이루어진 군으로부터 선택되는 어느 하나 이상을 포함할 수 있다.The cosmetic composition including the liposome may include the bioactive material and the carbon material in a weight ratio of 0.01 to 1:1. The bioactive material may include a whitening component, an antioxidant component, an anti-wrinkle component, a moisturizing component, and an anti-inflammatory component. It may include any one or more selected from the group consisting of components, skin regeneration components, and skin aging inhibitory components.
상기 미백 성분은 나이아신아마이드, 아데노신 및 레티노이드계 성분으로 이루어진 군에서 선택되는 하나 이상을 포함할 수 있다.The whitening component may include at least one selected from the group consisting of niacinamide, adenosine, and retinoid-based components.
상기 계면활성제는 폴리글리세릴-3메틸글루코오스다이스테아레이트, 글루코리피드, 리조레시친, 소르비탄 스테아레이트, 글리세릴 올레에이트, 글리세릴 스테아레이트, 폴리옥시알킬렌 알킬에테르, 폴리옥시알킬렌 지방산 에스테르, 알킬폴리 글루코사이드, 소듐 라우릴 에테르 설페이트, 스테아릴 트리메틸 염화암모늄, 알킬 폴리글리세릴에테르, 스테아릴트리메틸암모늄 클로라이드, 라우릴트리메틸 암모늄 클로라이드, 디스테아릴디메틸-암모늄 클로라이드, 폴리(N,N'-디메틸-3,5-메틸렌 피페리디늄) 클로라이드, 세틸피리디늄 클로라이드, 알킬테트라암모늄염, 알킬디메틸벤질암모늄염, 알킬이소퀴놀리늄염, 디알킬-모르폴리늄염, 폴리아민 지방산 유도체, 아밀 알코올 지방산 유도체, 벤즈알코늄 클로라이드, 벤즈에토늄 클로라이드 및 포타슘세틸포스페이트로 이루어진 군에서 선택되는 하나 이상을 포함할 수 있다.The surfactant is polyglyceryl-3methylglucose distearate, glucolipid, lysolecitin, sorbitan stearate, glyceryl oleate, glyceryl stearate, polyoxyalkylene alkyl ether, polyoxyalkylene fatty acid ester, Alkyl poly glucoside, sodium lauryl ether sulfate, stearyl trimethyl ammonium chloride, alkyl polyglyceryl ether, stearyl trimethyl ammonium chloride, lauryl trimethyl ammonium chloride, distearyl dimethyl-ammonium chloride, poly(N,N'-dimethyl -3,5-methylene piperidinium) chloride, cetylpyridinium chloride, alkyltetraammonium salt, alkyldimethylbenzylammonium salt, alkylisoquinolinium salt, dialkyl-morpholinium salt, polyamine fatty acid derivative, amyl alcohol fatty acid derivative, benzal It may include at least one selected from the group consisting of conium chloride, benzethonium chloride, and potassium cetyl phosphate.
상기 지질은 대두 레시틴, 난황 레시틴, 하이드로제네이티드 레시틴, 하이드로제네이티드 라이소레시틴, 하이드로옥실레이티드 레시틴, 토코페롤, 토코페릴아세테이트, 알루미늄/마그네슘하이드록사이드스테아레이트, 펜타에리스리틸테트라다이-t-부틸하이드록시하이드로신나메이트 및 카프릭트리글리세라이드로 이루어진 군에서 선택되는 하나 이상을 포함할 수 있다.The lipid is soybean lecithin, egg yolk lecithin, hydrogenated lecithin, hydrogenated lysolecithin, hydrooxylated lecithin, tocopherol, tocopheryl acetate, aluminum/magnesium hydroxide stearate, pentaerythrityltetradi-t- It may include at least one selected from the group consisting of butyl hydroxyhydrocinnamate and capric triglyceride.
상기 리포좀을 포함하는 화장료 조성물은 폴리올, 오일, 방부제 및 정제수로 이루어진 군에서 선택되는 하나 이상을 더 포함할 수 있다.The cosmetic composition containing the liposome may further include at least one selected from the group consisting of polyol, oil, preservative and purified water.
다른 양상은 상기 리포좀을 포함하는 피부외용제 조성물을 제공하는 데 있다.Another aspect is to provide a composition for external application for skin containing the liposome.
일 양상의 조성물은 나이아신아마이드를 포함하는 미백 성분과 풀러렌 및 풀러롤로 이루어진 군에서 선택되는 하나 이상을 포함하는 탄소 물질 등을 포함하는 유효 성분의 포집력이 우수하며, 리포좀의 안정성 및 피부 침투력이 현저히 우수할 수 있다.The composition of one aspect is excellent in trapping active ingredients including a whitening component including niacinamide and a carbon material including at least one selected from the group consisting of fullerene and fullerol, and the stability and skin penetration of liposomes are remarkably good. can be excellent
이에 따라, 본 실시예의 조성물은 미백, 주름 개선 등의 다양한 기능을 동시에 구현함으로써, 우수한 피부 개선 효과를 가질 수 있다.Accordingly, the composition of the present embodiment can have excellent skin improvement effects by simultaneously implementing various functions such as whitening and wrinkle improvement.
아래에서는 본 발명이 속하는 기술 분야에서 통상의 지식을 가진 자가 용이하게 실시할 수 있도록 본 발명의 실시예를 상세히 설명한다. 그러나 본 발명은 여러 가지 상이한 형태로 구현될 수 있으며 여기에서 설명하는 실시예에 한정되지 않는다.Hereinafter, embodiments of the present invention will be described in detail so that those skilled in the art can easily practice the present invention. However, the present invention may be embodied in many different forms and is not limited to the embodiments described herein.
본 발명의 명세서 및 청구범위에 사용된 용어 또는 단어는 통상적이거나 사전적인 의미로 한정 해석되지 아니하며, 발명자는 그 자신의 발명을 가장 최선의 방법으로 설명하기 위해 용어의 개념을 적절하게 정의할 수 있다는 원칙에 입각하여 본 발명의 기술적 사상에 부합하는 의미와 개념으로 해석되어야만 한다.Terms or words used in the specification and claims of the present invention are not limited to the usual or dictionary meaning, and the inventor can properly define the concept of the term in order to explain his/her invention in the best way. Based on the principle, it should be interpreted as a meaning and concept consistent with the technical idea of the present invention.
본 발명의 명세서 전체에 있어서, 어떤 부분이 어떤 구성 요소를 "포함" 한다고 할 때, 이는 특별히 반대되는 기재가 없는 한 다른 구성 요소를 제외하는 것이 아니라 다른 구성 요소를 더 포함할 수 있는 것을 의미한다.Throughout the specification of the present invention, when a part "includes" a certain component, it means that it may further include other components, not excluding other components unless otherwise stated. .
본 발명의 명세서 전체에 있어서, "A 및/또는 B"는, A 또는 B, 또는 A 및 B를 의미한다.Throughout the specification of the present invention, "A and/or B" means A or B, or A and B.
이하에서 본 발명을 구체적으로 설명하였으나, 본 발명이 이에 제한되는 것은 아니다.Although the present invention has been specifically described below, the present invention is not limited thereto.
일 양상은 유효 성분의 포집력이 우수한 리포좀을 포함하는 화장료 조성물을 제공한다.One aspect provides a cosmetic composition comprising a liposome having excellent trapping ability of an active ingredient.
일 구체예에서는 생리활성물질; 풀러렌(Fullerene) 및 풀러롤(Fullerol)로 이루어진 군에서 선택되는 하나 이상을 포함하는 탄소 물질; 계면활성제; 및 지질;을 포함하는 리포좀을 포함하는 화장료 조성물을 제공한다.In one embodiment, a physiologically active substance; A carbon material containing at least one selected from the group consisting of fullerene and fullerol; Surfactants; And lipids; It provides a cosmetic composition comprising a liposome containing.
일 구체예에서, 상기 리포좀은 지질 및 계면활성제를 포함하는 지질 이중충의 구형 베지클일 수 있으며, 상기 구형 베지클의 내부에는 탄소 물질 또는 생리활성물질이 담지될 수 있다.In one embodiment, the liposome may be a spherical vesicle of a lipid double layer including a lipid and a surfactant, and a carbon material or a physiologically active material may be supported inside the spherical vesicle.
상기 리포좀의 직경은 5 내지 1,500 nm, 예를 들면, 5 내지 1,000 nm, 10 내지 1,500 nm, 10 내지 1,000 nm, 10 내지 800 nm, 10 내지 500 nm, 5 내지 500 nm, 5 내지 300 nm, 10 내지 300 nm, 5 내지 200 nm, 5 내지 100nm, 또는 10 내지 100 nm 일 수 있다.The diameter of the liposome is 5 to 1,500 nm, for example, 5 to 1,000 nm, 10 to 1,500 nm, 10 to 1,000 nm, 10 to 800 nm, 10 to 500 nm, 5 to 500 nm, 5 to 300 nm, 10 to 300 nm, 5 to 200 nm, 5 to 100 nm, or 10 to 100 nm.
일 구체예의 리포좀을 포함하는 화장료 조성물은 생리활성물질, 탄소 물질 등 복수의 유효성분을 포함함으로써, 미백과 주름 개선 등 다양한 효능을 구현할 수 있다. 특히, 일 구체예의 리포좀을 포함하는 화장료 조성물은 유효 성분의 포집력이 우수하며, 리포좀 자체의 안정성이 우수하고, 피부 침투율이 좋아, 실질적인 피부 개선 효과가 우수할 수 있다.The cosmetic composition containing liposomes of one embodiment can implement various effects such as whitening and wrinkle improvement by including a plurality of active ingredients such as physiologically active substances and carbon materials. In particular, the cosmetic composition containing the liposome of one embodiment has excellent trapping ability of active ingredients, excellent stability of the liposome itself, and good skin penetration rate, so that the skin improvement effect may be excellent.
이하에서는 리포좀을 포함하는 화장료 조성물의 구성 성분에 대해 상세히 설명하도록 하겠다.Hereinafter, the components of the cosmetic composition containing liposomes will be described in detail.
일 구체예의 리포좀을 포함하는 화장료 조성물은 생리활성물질, 예를 들면, 미백 성분, 항산화 성분, 주름 개선 성분, 보습 성분, 항염증 성분, 피부재생 성분, 또는 피부노화 억제 성분을 포함할 수 있다.A cosmetic composition containing a liposome of one embodiment may include a physiologically active substance, for example, a whitening component, an antioxidant component, a wrinkle improvement component, a moisturizing component, an anti-inflammatory component, a skin regeneration component, or a skin aging inhibitory component.
본 명세서에서 용어, "생리활성물질(physiologically active substances)"은 개체에 유용한 활성, 예를 들면, 피부 재생, 피부 항노화, 피부 주름, 피부 미백, 피부 보습 등을 부여할 수 있는 물질을 의미할 수 있다.As used herein, the term "physiologically active substances" means substances capable of imparting useful activities to a subject, for example, skin regeneration, skin anti-aging, skin wrinkles, skin whitening, skin moisturizing, and the like. can
상기 생리활성물질은 상기 리포좀에 담지된 것일 수 있다.The bioactive material may be supported in the liposome.
일 구체예의 미백 성분은 미백 효과를 구현할 수 있는 공지의 모든 성분을 포함할 수 있다.The whitening component of one embodiment may include all known components capable of implementing a whitening effect.
구체적으로, 일 구체예의 미백 성분은 나이아신아마이드, 아데노신 및 레티노이드계 성분으로 이루어진 군에서 선택되는 하나 이상을 포함할 수 있다. 더 구체적으로, 일 구체예의 미백 성분은 나이아신아마이드를 포함할 수 있으나, 이에 제한되지 않는다.Specifically, the whitening component of one embodiment may include one or more selected from the group consisting of niacinamide, adenosine, and retinoid-based components. More specifically, the whitening component of one embodiment may include niacinamide, but is not limited thereto.
이때, 상기 레티노이트계 성분은 비타민 A의 유도체를 의미하며, 예를 들어, 레티놀(retinol), 레티날(retinal), 레티노인산(retinoic acid), 레티닐 아세테이트(retinyl acetate), 레티닐 프로피오네이트(retinyl propionate), 레티닐 리놀리에이트 (retinyl linoleate) 및 레티닐 팔미테이트(retinyl palmitate)로 이루어진 군에서 선택되는 하나 이상을 포함할 수 있다.At this time, the retinoid-based component means a derivative of vitamin A, and for example, retinol, retinal, retinoic acid, retinyl acetate, retinyl propionate ( retinyl propionate), retinyl linoleate, and retinyl palmitate.
일 구체예의 리포좀을 포함하는 화장료 조성물은 화장료 조성물 총 중량 기준으로 생리활성물질을 0.0001 ~ 1.0 중량%, 구체적으로는 0.0003 ~ 0.1 중량%로 포함할 수 있다. 일 구체예의 리포좀을 포함하는 화장료 조성물이 생리활성물질을 포함하되, 상기 생리활성물질을 0.0001 ~ 1.0 중량%로 포함할 때, 적정 크기의 리포좀이 안정적인 상태를 장기간 유지하면서도 유효 성분 포집율, 피부 침투율 및 피부 개선 효과가 더욱 우수할 수 있다.The cosmetic composition containing the liposome of one embodiment may include 0.0001 to 1.0% by weight, specifically 0.0003 to 0.1% by weight of the physiologically active material based on the total weight of the cosmetic composition. A cosmetic composition containing liposomes of one embodiment includes a physiologically active substance, but when the physiologically active substance is included in an amount of 0.0001 to 1.0% by weight, the liposome of an appropriate size maintains a stable state for a long period of time while maintaining active ingredient capture rate and skin penetration rate And the skin improvement effect may be more excellent.
만약, 일 구체예의 리포좀을 포함하는 화장료 조성물이 총 중량 기준으로 생리활성물질을 0.0001 중량% 미만으로 포함할 경우에는, 상기 생리활성물질을 0.0001 ~ 1.0 중량%로 포함하는 경우 보다, 피부 개선 효과가 저하될 수 있다. 반면, 일 구체예의 리포좀을 포함하는 화장료 조성물이 총 중량 기준으로 생리활성물질을 1.0 중량% 초과로 포함할 경우에는, 상기 생리활성물질을 0.0001 ~ 1.0 중량%로 포함하는 경우 보다, 리포좀의 안정성이 저하되고, 유효 성분의 포집율과 피부 침투율이 저하되어, 피부 개선 효과의 향상 정도가 미미할 수 있다.If the cosmetic composition containing the liposome of one embodiment contains less than 0.0001% by weight of the physiologically active material based on the total weight, the skin improvement effect is greater than when the cosmetic composition contains 0.0001 to 1.0% by weight of the physiologically active material. may be lowered On the other hand, when the cosmetic composition containing the liposome of one embodiment contains more than 1.0% by weight of the physiologically active material based on the total weight, the stability of the liposome is higher than when the cosmetic composition contains 0.0001 to 1.0% by weight of the physiologically active material. decrease, and the capture rate and skin penetration rate of active ingredients are reduced, and the degree of improvement of the skin improvement effect may be insignificant.
일 구체예의 리포좀을 포함하는 화장료 조성물은 탄소 물질을 포함한다.A cosmetic composition comprising a liposome of one embodiment includes a carbon material.
일 구체예의 리포좀을 포함하는 화장료 조성물은 풀러렌(Fullerene) 및 풀러롤(Fullerol)로 이루어진 군에서 선택되는 하나 이상을 포함하는 탄소 물질을 포함할 수 있다.The cosmetic composition containing liposomes of one embodiment may include a carbon material containing at least one selected from the group consisting of fullerene and fullerol.
상기 풀러렌(Fullerene)은 탄소 원자가 구, 타원체, 원기둥 모양으로 배치된 분자를 통칭하는 것으로, 통상적으로 구형의 탄소 물질을 의미하며, 항산화, 미백, 주름 개선 효과를 가지는 것으로 알려져 있다. 또한, 상기 풀러롤(Fullerol)은 풀러렌에 하이드록실기를 도입한 것으로, 하이드록실레이티드 풀러렌(hydroxylated fullerene)으로도 불린다.The fullerene refers to a molecule in which carbon atoms are arranged in a spherical, ellipsoidal, or cylindrical shape, and generally means a spherical carbon material, and is known to have antioxidant, whitening, and anti-wrinkle effects. In addition, the fullerol is obtained by introducing a hydroxyl group into fullerene, and is also called hydroxylated fullerene.
일 구체예의 탄소 물질은 상기와 같은 풀러렌 또는 풀러롤을 각각 단독으로 포함할 수 있다.The carbon material of one embodiment may include each of the above fullerenes or fullerols alone.
구체적으로, 일 구체예의 탄소 물질은 상기 풀러렌 및 풀러롤을 모두 포함할 수 있다. 특히, 일 구체예의 탄소 물질이 상기 풀러렌 및 풀러롤을 모두 포함할 경우에는, 풀러렌 또는 풀러롤을 각각 단독으로 포함하는 경우 보다, 리포좀의 유효 성분의 포집율이 좋고, 리포좀의 안정성 및 피부 침투율이 우수하여, 피부 개선 효과가 향상될 수 있다.Specifically, the carbon material of one embodiment may include both the fullerene and the fullerol. In particular, when the carbon material of one embodiment includes both the fullerene and the fullerol, the capture rate of the active ingredient of the liposome is better than when the fullerene or the fullerol is included alone, and the stability and skin penetration rate of the liposome are improved. It is excellent, and the skin improvement effect can be improved.
더 구체적으로, 일 구체예의 탄소 물질은 상기 풀러렌 및 풀러롤을 모두 포함하되, 상기 풀러렌 및 풀러롤을 0.1 ~ 10 : 1 의 중량비로 포함할 수 있다. 특히, 일 구체예의 탄소 물질이 상기 풀러렌 및 풀러롤을 0.1 ~ 10 : 1 의 중량비로 포함할 때, 리포좀의 유효 성분의 포집율이 좋고, 리포좀의 안정성 및 피부 침투율이 우수하여, 피부 개선 효과가 현저히 향상될 수 있다.More specifically, the carbon material of one embodiment includes both the fullerene and the fullerol, and may include the fullerene and the fullerol in a weight ratio of 0.1 to 10:1. In particular, when the carbon material of one embodiment includes the fullerene and the fullerol in a weight ratio of 0.1 to 10: 1, the liposome has a good capture rate of active ingredients, and the liposome has excellent stability and skin penetration, so that the skin improvement effect is obtained. can be significantly improved.
가장 구체적으로, 일 구체예의 탄소 물질은 상기 풀러렌 및 풀러롤을 모두 포함하되, 상기 풀러렌 및 풀러롤을 1 ~ 3 : 1 의 중량비로 포함할 수 있다. 특히, 일 구체예의 탄소 물질이 상기 풀러렌 및 풀러롤을 1 ~ 3 : 1 의 중량비로 포함할 때, 리포좀의 유효 성분의 포집율이 좋고, 리포좀의 안정성 및 피부 침투율이 우수하여, 피부 개선 효과가 현저히 우수할 수 있다.Most specifically, the carbon material of one embodiment includes both the fullerene and the fullerol, and may include the fullerene and the fullerol in a weight ratio of 1 to 3:1. In particular, when the carbon material of one embodiment includes the fullerene and the fullerol in a weight ratio of 1 to 3: 1, the liposome has a good capture rate of active ingredients, excellent liposome stability and skin penetration, and has a skin improvement effect. can be significantly better.
일 구체예의 리포좀을 포함하는 화장료 조성물은 조성물 총 중량 기준으로 탄소 물질을 0.001 ~ 3.0 중량%, 구체적으로는 0.01 ~ 2 중량%로 포함할 수 있다. 특히, 일 구체예의 리포좀을 포함하는 화장료 조성물이 탄소 물질을 포함하되, 총 중량 기준으로 0.001 ~ 3.0 중량%로 포함할 때, 적정 크기의 리포좀이 안정적인 상태를 장기간 유지하면서도 유효 성분 포집율, 피부 침투율 및 피부 개선 효과가 더욱 우수할 수 있다.The cosmetic composition containing the liposome of one embodiment may include 0.001 to 3.0% by weight, specifically 0.01 to 2% by weight of the carbon material based on the total weight of the composition. In particular, when the cosmetic composition containing liposomes of one embodiment includes carbon materials in an amount of 0.001 to 3.0% by weight based on the total weight, the active ingredient capture rate and skin penetration rate while maintaining a stable state for a long period of time while keeping the liposomes of an appropriate size stable. And the skin improvement effect may be more excellent.
만약, 일 구체예의 리포좀을 포함하는 화장료 조성물이 총 중량 기준으로 탄소 물질을 0.001 중량% 미만으로 포함할 경우에는, 상기 탄소 물질을 0.001 ~ 3.0 중량%로 포함하는 경우 보다, 유효 성분의 포집율과 리포좀의 안정성 및 피부 침투율이 저하되어, 피부 개선 효과의 향상 정도가 미미할 수 있다. 반면, 일 구체예의 리포좀을 포함하는 화장료 조성물이 총 중량 기준으로 탄소 성분을 3.0 중량% 초과로 포함할 경우에는, 상기 탄소 물질을 0.001 ~ 3.0 중량%로 포함하는 경우 보다, 리포좀의 안정성이 저하되고, 유효 성분의 포집율과 피부 침투율이 저하되어, 피부 개선 효과의 향상 정도가 미미할 수 있다.If the cosmetic composition containing the liposome of one embodiment contains less than 0.001% by weight of the carbon material based on the total weight, the capture rate of the active ingredient and The stability and skin permeation rate of liposomes are lowered, so the degree of improvement in the skin improvement effect may be insignificant. On the other hand, when the cosmetic composition containing the liposome of one embodiment contains more than 3.0% by weight of the carbon component based on the total weight, the stability of the liposome is lowered than when the carbon material is included in 0.001 to 3.0% by weight. , the capture rate and skin penetration rate of active ingredients are lowered, so the degree of improvement in the skin improvement effect may be insignificant.
일 구체예의 리포좀을 포함하는 화장료 조성물은, 상기 생리활성물질 및 상기 탄소 물질을 0.01 ~ 1 : 1 의 중량비로 포함할 수 있으며, 이 경우, 적정 크기의 리포좀이 형성되어, 장기간 안정적인 상태를 유지할 수 있으면서도 리포좀의 유효 성분 포집율과 피부 침투율이 우수하여, 피부가 효과적으로 개선될 수 있다. 반면, 상기 생리활성물질 및 상기 탄소 물질이 0.01 ~ 1 : 1의 중량비로 포함되지 않을 경우에는, 리포좀에 포집되지 않는 잔류 생리활성물질에 의해, 리포좀의 안정성이 저하되고, 피부 개선효과가 저하되는 문제가 있을 수 있다.The cosmetic composition containing liposomes of one embodiment may include the bioactive material and the carbon material in a weight ratio of 0.01 to 1: 1, in which case, liposomes of an appropriate size are formed and can maintain a stable state for a long period of time. However, the active ingredient capture rate and skin penetration rate of liposomes are excellent, so the skin can be effectively improved. On the other hand, when the bioactive material and the carbon material are not included in a weight ratio of 0.01 to 1: 1, the stability of the liposome is lowered and the skin improvement effect is lowered due to the remaining physiologically active material that is not captured in the liposome. There may be a problem.
일 구체예의 리포좀을 포함하는 화장료 조성물은 계면활성제를 포함한다.A cosmetic composition comprising the liposome of one embodiment includes a surfactant.
일 구체예의 리포좀을 포함하는 화장료 조성물은 폴리글리세릴-3메틸글루코오스다이스테아레이트, 글루코리피드, 리조레시친, 소르비탄 스테아레이트, 글리세릴 올레에이트, 글리세릴 스테아레이트, 폴리옥시알킬렌 알킬에테르, 폴리옥시알킬렌 지방산에스테르, 알킬폴리글루코사이드, 소듐 라우릴 에테르 설페이트, 스테아릴 트리메틸 염화암모늄, 알킬폴리글리세릴에테르, 스테아릴트리메틸암모늄 클로라이드, 라우릴트리메틸 암모늄 클로라이드, 디스테아릴디메틸-암모늄 클로라이드, 폴리(N,N′-디메틸-3,5-메틸렌피페리디늄) 클로라이드, 세틸피리디늄 클로라이드, 알킬테트라암모늄염, 알킬디메틸벤질암모늄염, 알킬이소퀴놀리늄염, 디알킬-모르폴리늄염, 폴리아민 지방산 유도체, 아밀 알코올 지방산 유도체, 벤즈알코늄 클로라이드, 벤즈에토늄 클로라이드 및 포타슘세틸포스페이트로 이루어진 군에서 선택되는 하나 이상을 포함하는 계면활성제를 포함할 수 있다.The cosmetic composition containing the liposome of one embodiment is polyglyceryl-3methylglucose distearate, glucolipid, lysolecitin, sorbitan stearate, glyceryl oleate, glyceryl stearate, polyoxyalkylene alkyl ether, poly Oxyalkylene fatty acid ester, alkyl polyglucoside, sodium lauryl ether sulfate, stearyl trimethyl ammonium chloride, alkyl polyglyceryl ether, stearyl trimethyl ammonium chloride, lauryl trimethyl ammonium chloride, distearyl dimethyl-ammonium chloride, poly( N,N′-dimethyl-3,5-methylenepiperidinium) chloride, cetylpyridinium chloride, alkyltetraammonium salt, alkyldimethylbenzylammonium salt, alkylisoquinolinium salt, dialkyl-morpholinium salt, polyamine fatty acid derivative, amyl It may include a surfactant including at least one selected from the group consisting of alcohol fatty acid derivatives, benzalkonium chloride, benzethonium chloride, and potassium cetyl phosphate.
구체적으로, 일 구체예의 계면활성제는 폴리글리세릴-3메틸글루코오스다이스테아레이트를 포함할 수 있다. 특히, 상기 폴리글리세릴-3메틸글루코오스다이스테아레이트는 edge activator 성분으로서, 리포좀 내부로 유효 성분이 쉽게 들어갈 수 있도록 하여 유효 성분의 포집율을 높이면서도, 리포좀의 탄성을 높여 우수한 피부 투과율을 구현하도록 할 수 있다.Specifically, the surfactant of one embodiment may include polyglyceryl-3methylglucose distearate. In particular, the polyglyceryl-3methylglucose distearate is an edge activator component, so that the active ingredient can easily enter the liposome to increase the capture rate of the active ingredient, while increasing the elasticity of the liposome to realize excellent skin permeability. can do.
일 구체예의 리포좀을 포함하는 화장료 조성물은 화장료 조성물 총 중량 기준으로 계면활성제를 0.001 ~ 1.0 중량%, 구체적으로는 0.01 ~ 0.5 중량%로 포함할 수 있다. 특히, 일 구체예의 리포좀을 포함하는 화장료 조성물이 계면활성제를 포함하되, 총 중량 기준으로 0.001 ~ 1.0 중량%로 포함할 때, 적정 크기의 리포좀이 안정적인 상태를 장기간 유지하면서도 유효 성분 포집율, 피부 침투율 및 피부 개선 효과가 더욱 우수할 수 있다.The cosmetic composition containing the liposome of one embodiment may include 0.001 to 1.0% by weight, specifically 0.01 to 0.5% by weight of a surfactant based on the total weight of the cosmetic composition. In particular, when the cosmetic composition containing liposomes of one embodiment includes a surfactant in an amount of 0.001 to 1.0% by weight based on the total weight, the active ingredient capture rate and skin penetration rate while maintaining a stable state for a long period of time while maintaining a stable state of liposomes of appropriate size And the skin improvement effect may be more excellent.
만약, 일 구체예의 리포좀을 포함하는 화장료 조성물이 총 중량 기준으로 계면활성제를 0.001 중량% 미만으로 포함할 경우에는, 상기 계면활성제를 0.001 ~ 1.0 중량%로 포함하는 경우 보다, 유효 성분의 포집율과 리포좀의 안정성 및 피부 침투율이 저하되어, 피부 개선 효과의 향상 정도가 미미할 수 있다. 반면, 일 구체예의 리포좀을 포함하는 화장료 조성물이 총 중량 기준으로 계면활성제를 1.0 중량% 초과로 포함할 경우에는, 상기 계면활성제를 0.001 ~ 1.0 중량%로 포함하는 경우 보다, 리포좀의 안정성이 저하되고, 유효 성분의 포집율과 피부 침투율이 저하되어, 피부 개선 효과의 향상 정도가 미미할 수 있다.If the cosmetic composition containing the liposome of one embodiment contains less than 0.001% by weight of the surfactant based on the total weight, the capture rate of the active ingredient and The stability and skin permeation rate of liposomes are lowered, so the degree of improvement in the skin improvement effect may be insignificant. On the other hand, when the cosmetic composition containing the liposome of one embodiment contains more than 1.0% by weight of the surfactant based on the total weight, the stability of the liposome is lowered than when the surfactant is included in 0.001 to 1.0% by weight. , the capture rate and skin penetration rate of active ingredients are lowered, so the degree of improvement in the skin improvement effect may be insignificant.
일 구체예의 리포좀을 포함하는 화장료 조성물은 지질을 포함한다.A cosmetic composition containing a liposome of one embodiment includes a lipid.
일 구체예의 리포좀을 포함하는 화장료 조성물은 대두 레시틴, 난황 레시틴, 하이드로제네이티드 레시틴, 하이드로제네이티드 라이소레시틴, 하이드로옥실레이티드 레시틴, 토코페롤, 토코페릴아세테이트, 알루미늄/마그네슘하이드록사이드스테아레이트, 펜타에리스리틸테트라-다이-t-부틸하이드록시하이드로신나메이트 및 카프릭트리글리세라이드로 이루어진 군에서 선택되는 하나 이상을 포함하는 지질을 포함할 수 있다.The cosmetic composition comprising the liposome of one embodiment is soybean lecithin, egg yolk lecithin, hydrogenated lecithin, hydrogenated lysolecithin, hydroxylated lecithin, tocopherol, tocopheryl acetate, aluminum/magnesium hydroxide stearate, pentagram A lipid containing at least one selected from the group consisting of erythrityltetra-di-t-butylhydroxyhydrocinnamate and capric triglyceride may be included.
구체적으로, 일 구체예의 리포좀을 포함하는 화장료 조성물은 인지질일 수 있으며, 상기 인지질은 대두 레시틴, 난황 레시틴, 하이드로제네이티드 레시틴, 하이드로제네이티드 라이소레시틴 및 하이드로옥실레이티드 레시틴으로 이루어진 군에서 선택되는 하나 이상을 포함할 수 있다.Specifically, the cosmetic composition containing the liposome of one embodiment may be a phospholipid, wherein the phospholipid is selected from the group consisting of soybean lecithin, egg yolk lecithin, hydrogenated lecithin, hydrogenated lysolecithin and hydroxylated lecithin may contain one or more.
일 구체예의 리포좀을 포함하는 화장료 조성물은 조성물 총 중량 기준으로 지질을 0.2 ~ 5.0 중량%, 구체적으로는 0.2 ~ 1.0 중량%로 포함할 수 있다. 특히, 일 구체예의 리포좀을 포함하는 화장료 조성물이 지질을 포함하되, 총 중량 기준으로 0.2 ~ 5.0 중량%로 포함할 때, 적정 크기의 리포좀이 안정적인 상태를 장기간 유지하면서도 유효 성분 포집율, 피부 침투율 및 피부 개선 효과가 더욱 우수할 수 있다.The cosmetic composition containing the liposome of one embodiment may include 0.2 to 5.0% by weight of lipid, specifically 0.2 to 1.0% by weight based on the total weight of the composition. In particular, when the cosmetic composition containing liposomes of one embodiment includes lipids in an amount of 0.2 to 5.0% by weight based on the total weight, the liposomes of appropriate size maintain a stable state for a long period of time while maintaining active ingredient capture rate, skin penetration rate, and The skin improvement effect may be more excellent.
만약, 일 구체예의 리포좀을 포함하는 화장료 조성물이 총 중량 기준으로 지질을 0.2 중량% 미만으로 포함할 경우에는, 상기 지질을 0.2 ~ 5.0 중량%로 포함하는 경우 보다, 유효 성분의 포집율과 리포좀의 안정성 및 피부 침투율이 저하되어, 피부 개선 효과의 향상 정도가 미미할 수 있다. 반면, 일 구체예의 리포좀을 포함하는 화장료 조성물이 총 중량 기준으로 지질을 5.0 중량% 초과로 포함할 경우에는, 상기 지질을 0.2 ~ 5.0 중량%로 포함하는 경우 보다, 리포좀의 안정성이 저하되고, 유효 성분의 포집율과 피부 침투율이 저하되어, 피부 개선 효과의 향상 정도가 미미할 수 있다.If the cosmetic composition containing the liposome of one embodiment contains less than 0.2% by weight of the lipid based on the total weight, than the case where the lipid is contained in 0.2 to 5.0% by weight, the capture rate of the active ingredient and the Stability and skin penetration rate are lowered, and the degree of improvement of the skin improvement effect may be insignificant. On the other hand, when the cosmetic composition containing the liposome of one embodiment contains more than 5.0% by weight of lipid based on the total weight, the stability of the liposome is lowered than when it contains 0.2 to 5.0% by weight of the lipid, and the effective The collection rate and skin penetration rate of components are lowered, so the degree of improvement in the skin improvement effect may be insignificant.
일 구체예의 리포좀을 포함하는 화장료 조성물은 폴리올을 더 포함할 수 있다.The cosmetic composition comprising the liposome of one embodiment may further include a polyol.
더 상세히, 일 구체예의 리포좀을 포함하는 화장료 조성물은 폴리올을 0.01 ~ 60.0 중량%, 구체적으로는 1 ~ 40.0 중량%로 포함할 수 있으나, 이에 제한되지 않는다.In more detail, the cosmetic composition containing the liposome of one embodiment may include 0.01 to 60.0% by weight of polyol, specifically 1 to 40.0% by weight, but is not limited thereto.
일 구체예의 폴리올은 공지의 모든 폴리올을 포함할 수 있으며, 예를 들어, 상기 폴리올은 부틸렌글라이콜, 글리세린, 글리세롤, 프로판올, 1,2헥산디올, 1,3-부칠렌글라이콜, 프로필렌글라이콜, 디프로필렌글라이콜, 이소프렌글리콜, 솔비톨, 자일리톨, 에리스톨, 과당, 유당, 만니톨, 포도당, 설탕, 말토스 및 말티톨로 이루어진 군에서 선택되는 하나 이상을 포함할 수 있으나, 이에 제한되지 않는다.The polyol of one embodiment may include all known polyols. For example, the polyol may include butylene glycol, glycerin, glycerol, propanol, 1,2hexanediol, 1,3-butylene glycol, and propylene glycol. It may include one or more selected from the group consisting of lycol, dipropylene glycol, isoprene glycol, sorbitol, xylitol, erythritol, fructose, lactose, mannitol, glucose, sucrose, maltose, and maltitol, but is not limited thereto. don't
일 구체예의 리포좀을 포함하는 화장료 조성물은 오일을 더 포함할 수 있다.The cosmetic composition comprising the liposome of one embodiment may further include oil.
더 상세히, 일 구체예의 리포좀을 포함하는 화장료 조성물은 오일을 0.0001 ~ 10 중량%, 구체적으로는 0.001 ~ 5 중량%로 포함할 수 있으나, 이에 제한되지 않는다.In more detail, the cosmetic composition containing the liposome of one embodiment may include 0.0001 to 10% by weight of oil, specifically 0.001 to 5% by weight of oil, but is not limited thereto.
일 구체예의 오일은 공지의 모든 오일을 포함할 수 있으며, 예를 들어, 망고 버터 오일, 쉐어 버터 오일, 코코아 씨드 버터 오일, 마카다미아넛 오일, 올리브 오일, 미도우폼 씨드오일, 정제포도씨 오일, 로즈힙 오일, 사플라워 오일, 복숭아씨 오일, 썬플라워 씨드오일, 마카다미아씨 오일, 카프릴릴카보네이트, 스쿠알란, 네오펜틸글라이콜디헵타노에이트, 토코페릴아세테이트, 트리옥타노인, 탄소수 12 내지 15의 알킬에틸헥사노에이트, 옥틸도데실미리스테이트, 트리카프릴린, 옥틸도데실스테아로일스테아레이트, 비스-하이드록시에톡시프로필디메치콘, 카프릴릭/카프릭트리글리세라이드, 이소트리데실이소노나노에이트, 폴리글리세릴-2트리이소스테아레이트, 디이소스테아릴말레이트, 디펜타에리스라이트패티애씨드에스테르, 세틸에틸헥사노에이트, 세틸옥타노에이트, 오조케라이트, 글리세릴 트리옥타노에이트, 옥틸도데실미리스테이트, 이소프로필팔미테이트, 이소프로필미리스테이트, 옥틸팔미테이트, 페닐트리메치콘, 사이클로메치콘, 디메치콘, 데카메틸사이클로펜타실록산하이드로카본오일, 하이드로제네이티드 피이지-60 캐스터오일, 하이드로제네이티드 폴리이소부텐 및 하이드로제네이티드폴리데센으로 이루어진 군에서 선태되는 하나 이상을 포함할 수 있으나, 이에 제한되지 않는다.The oil of one embodiment may include all known oils, for example, mango butter oil, shea butter oil, cocoa seed butter oil, macadamia nut oil, olive oil, meadowfoam seed oil, refined grape seed oil, rosehip Oil, safflower oil, peach seed oil, sunflower seed oil, macadamia seed oil, caprylyl carbonate, squalane, neopentyl glycol diheptanoate, tocopheryl acetate, trioctanoin, C12-15 alkylethylhexane Noate, Octyldodecyl Myristate, Tricaprylin, Octyldodecyl Stearoyl Stearate, Bis-Hydroxyethoxypropyl Dimethicone, Caprylic/Capric Triglyceride, Isotridecyl Isononanoate, Polyglyceryl-2triisostearate, Diisostearyl Maleate, Dipentaerythrite Fatty Acid Ester, Cetylethylhexanoate, Cetyloctanoate, Ozokerite, Glyceryl Trioctanoate, Octyldodecyl Myristate, isopropyl palmitate, isopropyl myristate, octyl palmitate, phenyltrimethicone, cyclomethicone, dimethicone, decamethylcyclopentasiloxane hydrocarbon oil, hydrogenated PEG-60 castor oil, hydrogenated It may include one or more selected from the group consisting of tid polyisobutene and hydrogenated polydecene, but is not limited thereto.
일 구체예의 리포좀을 포함하는 화장료 조성물은 방부제를 더 포함할 수 있다.The cosmetic composition comprising the liposome of one embodiment may further include a preservative.
더 상세히, 일 구체예의 리포좀을 포함하는 화장료 조성물은 방부제를 0.1 ~ 10 중량%, 구체적으로는 0.5 ~ 2 중량%로 포함할 수 있으나, 이에 제한되지 않는다.In more detail, the cosmetic composition containing the liposome of one embodiment may include a preservative at 0.1 to 10% by weight, specifically 0.5 to 2% by weight, but is not limited thereto.
일 구체예의 방부제로는 공지의 모든 방부제가 포함될 수 있으며, 예를 들어, 1,2-헥산다이올 및 펜틸렌글라이콜로 이루어진 군에서 선택되는 하나 이상을 포함할 수 있으나, 이에 제한되지 않는다.Preservatives of one embodiment may include all known preservatives, and may include, for example, at least one selected from the group consisting of 1,2-hexanediol and pentylene glycol, but is not limited thereto.
일 구체예의 화장료 조성물은 상기된 성분 이외에 각 제형의 제제화에 필요한 부형제 또는 첨가제 등을 더 포함할 수 있다. 예를 들어, 상기 부형제 또는 첨가제는 계면활성제, 유화제, 유화보조제, 실리콘 폴리머, 안료, 색소, 향료, 방부제, 살균제, 산화안정제, 유기 용매, 유연화제, 산화방지제, 자유 라디칼 파괴제, 불투명화제, 안정화제, 에몰리언트, 소포제, 보습제, 비타민, 곤충 기피제, 보존제, 소염제, 충전제, 중합체, 추진제, 염기성화제, 산성화제, 착색제, 농화제, 피부컨디셔닝제, 미백제, 항산화제, 주름 개선제 및 용해화제로 이루어진 군에서 선택되는 하나 이상을 포함할 수 있으나, 이에 제한되지 않는다.The cosmetic composition of one embodiment may further include excipients or additives necessary for formulation of each formulation in addition to the above components. For example, the excipients or additives include surfactants, emulsifiers, emulsifiers, silicone polymers, pigments, colorants, fragrances, preservatives, bactericides, oxidation stabilizers, organic solvents, softeners, antioxidants, free radical destroyers, opacifiers, As a stabilizer, emollient, antifoam, moisturizer, vitamin, insect repellent, preservative, anti-inflammatory, filler, polymer, propellant, alkalizing agent, acidifying agent, colorant, thickening agent, skin conditioning agent, whitening agent, antioxidant, anti-wrinkle agent and solubilizing agent It may include one or more selected from the group consisting of, but is not limited thereto.
일 구체예의 화장료 조성물은 유연화장수, 영양화장수, 수렴화장수, 스킨, 로션, 에센스, 세럼, 크림, 마사지 크림, 팩, 메이크업 베이스, 비비크림, 파운데이션, 파우더, 클렌징 폼, 클렌징 크림 및 클렌징 워터로 이루어진 군에서 선택된 하나의 제형일 수 있으나, 이에 제한되지 않는다.The cosmetic composition of one embodiment consists of softening lotion, nutrient lotion, astringent lotion, toner, lotion, essence, serum, cream, massage cream, pack, makeup base, BB cream, foundation, powder, cleansing foam, cleansing cream and cleansing water It may be one formulation selected from the group, but is not limited thereto.
다른 양상은 생리활성물질; 풀러렌 및 풀러롤로 이루어진 군에서 선택되는 하나 이상을 포함하는 탄소 물질; 계면활성제; 및 지질;을 포함하는 리포좀을 포함하는 피부외용제 조성물을 제공한다.Another aspect is a bioactive substance; A carbon material containing at least one selected from the group consisting of fullerene and fullerol; Surfactants; And a lipid; It provides a composition for external application for skin comprising a liposome containing.
상기 생리활성물질, 탄소 물질, 계면활성제, 지질 및 리포좀은 상기한 바와 같다.The bioactive material, carbon material, surfactant, lipid and liposome are as described above.
상기 피부외용제는 크림, 겔, 연고, 피부 유화제, 피부 현탁액, 경피전달성 패치, 약물 함유 붕대, 로션, 또는 그 조합일 수 있다. 상기 피부외용제는 통상 화장품이나 의약품 등의 피부외용제에 사용되는 성분, 예를 들면 수성성분, 유성성분, 분말성분, 알코올류, 보습제, 증점제, 자외선흡수제, 미백제, 방부제, 산화방지제, 계면활성제, 향료, 색제, 각종 피부 영양제, 또는 이들의 조합과 필요에 따라서 적절하게 배합될 수 있다.The external skin preparation may be a cream, gel, ointment, skin emulsifier, skin suspension, transdermal delivery patch, drug-containing bandage, lotion, or a combination thereof. The external skin preparation is a component usually used in external preparations for skin such as cosmetics or pharmaceuticals, for example, water-based components, oil-based components, powder components, alcohols, moisturizers, thickeners, ultraviolet absorbers, whitening agents, preservatives, antioxidants, surfactants, and fragrances. , colorants, various skin nutrients, or combinations thereof and may be suitably blended as needed.
이하 실시예, 비교예, 및 실험예를 통하여 본 발명의 유효 성분의 포집력이 우수한 리포좀 화장료 조성물에 대해 구체적으로 설명하기로 한다. 이들 실시예는 단지 본 발명을 예시하기 위한 것이므로, 본 발명의 범위가 이들 실시예에 의해 제한되는 것으로 해석되지는 않는다.Hereinafter, the liposomal cosmetic composition having excellent trapping ability of the active ingredient of the present invention will be described in detail through Examples, Comparative Examples, and Experimental Examples. Since these examples are intended to illustrate the present invention only, the scope of the present invention is not to be construed as being limited by these examples.
[ 제조예 ] [Production Example]
제조 1 : 미백 성분 및 탄소 물질의 비율에 따른 평가Preparation 1: Evaluation according to the ratio of whitening ingredients and carbon materials
표 1[단위 : 중량%]에 따르도록 미백 성분, 탄소 물질, 계면활성제, 지질, 폴리올, 오일, 방부제 및 정제수를 혼합하여, 리포좀 화장료 조성물을 제조하였다.A liposome cosmetic composition was prepared by mixing the whitening component, carbon material, surfactant, lipid, polyol, oil, preservative and purified water according to Table 1 [unit: weight%].
이때, 표 1에서 미백 성분 및 탄소 물질(풀러렌 및 풀러롤을 1.5 : 1의 중량비로 포함)의 총 량은 0.04 중량% 이었고, 이들의 혼합 비율을 표 2[단위 : 중량비]에 따라 혼합하였다.At this time, in Table 1, the total amount of the whitening component and the carbon material (including fullerene and fullerol in a weight ratio of 1.5: 1) was 0.04% by weight, and their mixing ratio was mixed according to Table 2 [unit: weight ratio].
또한, 미백 성분으로는 나이아신아마이드를 사용하였으며, 계면활성제로는 폴리글리세릴-3메틸글루코오스다이스테아레이트(상품명 : TEGOCARE 450)를 사용하였고, 지질은 인지질을 사용하였다.In addition, niacinamide was used as a whitening component, polyglyceryl-3methylglucose distearate (trade name: TEGOCARE 450) was used as a surfactant, and phospholipid was used as a lipid.
실시예 1, 실시예 2 및 비교예 1Example 1, Example 2 and Comparative Example 1
미백성분whitening ingredient 0.040.04
탄소물질carbon material 풀러렌fullerene
풀러롤fuller roll
계면활성제Surfactants 0.10.1
지질lipids 1.01.0
폴리올polyol 4040
오일oil 0.0010.001
방부제antiseptic 0.010.01
정제수Purified water to. 100to. 100
실시예 1Example 1 실시예 2Example 2 비교예 1Comparative Example 1
미백 성분whitening ingredients 1One 0.010.01 1.21.2
탄소 물질carbon material 1One 1One 1One
제조 2 : 풀러렌 및 풀러롤 사용에 따른 평가Manufacture 2: Evaluation according to the use of fullerene and fullerol
표 3[단위 : 중량%]에 따르도록 미백 성분, 탄소 물질, 계면활성제, 지질, 폴리올, 오일, 방부제 및 정제수를 혼합하여, 리포좀 조성물을 제조한 것을 제외하고는, 실시예 1과 동일하게 실시하였다.The whitening component, carbon material, surfactant, lipid, polyol, oil, preservative and purified water were mixed according to Table 3 [unit: weight%], except that the liposome composition was prepared, and carried out in the same manner as in Example 1. did
이때, 표 3에서 탄소 물질을 구성하는 풀러렌 및 풀러롤의 혼합 비율은 표 4[단위 : 중량비]에 따라 혼합하였으며, 표 4에는 실시예 1에서 풀러렌과 풀러롤의 혼합 비율을 함께 기재하였다.At this time, in Table 3, the mixing ratio of fullerene and fullerol constituting the carbon material was mixed according to Table 4 [unit: weight ratio], and in Table 4, the mixing ratio of fullerene and fullerol in Example 1 was also described.
실시예 3 내지 7Examples 3 to 7
미백성분whitening ingredient 0.020.02
탄소물질carbon material 풀러렌fullerene 0.020.02
풀러롤fuller roll
계면활성제Surfactants 0.10.1
지질lipids 1.01.0
폴리올polyol 4040
오일oil 0.0010.001
방부제antiseptic 2.02.0
정제수Purified water to. 100to. 100
실시예 1Example 1 실시예 3Example 3 실시예 4Example 4 실시예 5Example 5 실시예 6Example 6 실시예 7Example 7
풀러렌fullerene 1.51.5 -- 0.110.11 0.670.67 99 1One
플라럴floral 1One 1One 1One 1One 1One --
[ 실험예 ][Experimental example]
실험예 1 : 나이아신아마이드의 포집율 평가Experimental Example 1: Evaluation of capture rate of niacinamide
상기 실시예 1 내지 7 및 비교예 1의 리포좀 화장료 조성물에서, 나이아신아마이드 포집율을 평가하고, 그 결과를 표 5[단위 : %]에 나타내었다.In the liposomal cosmetic compositions of Examples 1 to 7 and Comparative Example 1, the niacinamide capture rate was evaluated, and the results are shown in Table 5 [Unit: %].
구체적으로, 상기 나이아신아마이드의 포집율은 원심분리 이후 상층액을 떠서 HPLC로 나이아신아마이드 농도를 확인(잔류한 나이아신아마이드)하고, 이를 이용하여 '포집율(%) = (초기 나이아신아마이드 함량 - 상층액에 포함된 나이아신아마이드)/(초기 나이아신아마이드 함량) * 100%'로 계산함으로써, 측정되었다.Specifically, the capture rate of the niacinamide is obtained by scooping the supernatant after centrifugation, checking the niacinamide concentration (remaining niacinamide) by HPLC, and using this, 'capture rate (%) = (initial niacinamide content - supernatant) Niacinamide contained in)/(initial niacinamide content) * 100%' was calculated.
포집율(%)Capture rate (%) 포집율(%)Capture rate (%)
실시예 1Example 1 100100 실시예 5Example 5 9595
실시예 2Example 2 100100 실시예 6Example 6 9292
실시예 3Example 3 8888 실시예 7Example 7 8989
실시예 4Example 4 9595 비교예 1Comparative Example 1 100(미포집 나이아신아마이드 잔류)100 (uncaptured niacinamide residue)
표 5에서, 실시예 1, 실시예 2 및 비교예 1을 보면, 리포좀 화장료 조성물이 미백 성분 및 탄소 물질을 0.01 ~ 1 : 1 의 중량비로 포함할 때, 리포좀에 포집되지 못하고 잔류되는 미백 성분이 없으면서도 미백 성분의 포집율이 100 %로 매우 우수함을 알 수 있다. 특히, 비교예 1의 경우에는, 탄소 물질에 비해 미백 성분이 과량 포함되어, 미포집 나이아신아마이드가 잔류되는 바, 미포집 나이아신아마이드는 피부에 효과적으로 흡수되지 못하여 경제적이지 못할 수 있다. 뿐만 아니라, 나이아신아마이드 성분이 외부에 노출되어 변색 또는 산화 등의 문제를 일으킬 수 있고, 피부에 자극을 줄 수 있다.In Table 5, looking at Example 1, Example 2 and Comparative Example 1, when the liposomal cosmetic composition includes a whitening component and a carbon material in a weight ratio of 0.01 to 1: 1, the whitening component remaining without being captured in the liposome It can be seen that the collection rate of the whitening component is 100%, which is very excellent. In particular, in the case of Comparative Example 1, since the whitening component is included in an excessive amount compared to the carbon material, unencapsulated niacinamide remains, and thus, unencapsulated niacinamide may not be effectively absorbed into the skin and may not be economical. In addition, the niacinamide component may be exposed to the outside and cause problems such as discoloration or oxidation, and may cause skin irritation.
또한, 실시예 1과 실시예 3 내지 7을 비교하면, 탄소 물질이 풀러렌 또는 풀러롤을 각각 단독으로 포함하는 경우에도 88 % 이상으로 포집율이 높음을 알 수 있으며, 바람직하게 탄소 물질이 풀러렌 및 풀러롤을 모두 포함하는 경우에는 92 % 이상으로 포집율이 더욱 향상됨을 알 수 있다. 특히, 탄소 물질에서 풀러렌 및 풀러롤의 혼합 비율이 3 : 2의 중량비에 따를 경우에, 100 %로 미백 성분의 포집율이 가장 우수함을 알 수 있다.In addition, when comparing Example 1 and Examples 3 to 7, it can be seen that the collection rate is as high as 88% or more even when the carbon material includes fullerene or fullerol alone, and preferably the carbon material is fullerene and fullerol. It can be seen that the collection rate is further improved to 92% or more when all of the fullerols are included. In particular, it can be seen that when the mixing ratio of fullerene and fullerol in the carbon material is 3:2, the whitening component capture rate is the best at 100%.
[ 제조예 ][Production Example]
제조 3 : 탄소 물질 종류에 따른 평가Manufacture 3: Evaluation according to the type of carbon material
표 6[단위 : 중량%]에 따르도록 미백 성분, 탄소 물질, 계면활성제, 지질, 폴리올, 오일, 방부제 및 정제수를 혼합하여, 리포좀 화장료 조성물을 제조하였다.A liposome cosmetic composition was prepared by mixing the whitening component, carbon material, surfactant, lipid, polyol, oil, preservative and purified water according to Table 6 [unit: weight%].
또한, 미백 성분으로는 나이아신아마이드를 사용하였으며, 계면활성제로는 폴리글리세릴-3메틸글루코오스다이스테아레이트(상품명 : TEGOCARE 450)를 사용하였고, 지질은 인지질을 사용하였다.In addition, niacinamide was used as a whitening component, polyglyceryl-3methylglucose distearate (trade name: TEGOCARE 450) was used as a surfactant, and phospholipid was used as a lipid.
실시예 8Example 8 실시예 9Example 9 실시예 10Example 10
미백성분whitening ingredient 0.010.01 0.010.01 0.010.01
탄소물질carbon material 풀러렌fullerene 0.0060.006 0.010.01 --
풀러롤fuller roll 0.0040.004 -- 0.010.01
계면활성제Surfactants 0.10.1 0.10.1 0.10.1
지질lipids 1.01.0 1.01.0 1.01.0
폴리올polyol 40.040.0 40.040.0 40.040.0
오일oil 0.0010.001 0.0010.001 0.0010.001
방부제antiseptic 2.02.0 2.02.0 2.02.0
정제수Purified water to. 100to. 100
제조 4 : 지질 함량에 따른 평가Preparation 4: Evaluation according to lipid content
표 7[단위 : 중량%]에 따르도록 미백 성분, 탄소 물질, 계면활성제, 지질, 폴리올, 오일, 방부제 및 정제수를 혼합하여, 리포좀 화장료 조성물을 제조한 것을 제외하고는, 실시예 8과 동일하게 실시하였다.In the same manner as in Example 8, except that the liposome cosmetic composition was prepared by mixing the whitening component, carbon material, surfactant, lipid, polyol, oil, preservative and purified water according to Table 7 [unit: weight%]. conducted.
이때, 표 7에 실시예 8의 조성물의 내용을 함께 기재하였다.At this time, the contents of the composition of Example 8 were also described in Table 7.
실시예 8Example 8 실시예 11Example 11 비교예 2Comparative Example 2
미백성분whitening ingredient 0.010.01 0.010.01 0.010.01
탄소물질carbon material 풀러렌fullerene 0.0060.006 0.0060.006 0.0060.006
풀러롤fuller roll 0.0040.004 0.0040.004 0.0040.004
계면활성제Surfactants 0.10.1 0.10.1 0.10.1
지질lipids 1.01.0 1.31.3 0.160.16
폴리올polyol 40.040.0 40.040.0 40.040.0
오일oil 0.0010.001 0.0010.001 0.0010.001
방부제antiseptic 2.02.0 2.02.0 2.02.0
정제수Purified water to. 100to. 100
제조 5 : 계면활성제 함량에 따른 평가Preparation 5: Evaluation according to surfactant content
표 8[단위 : 중량%]에 따르도록 미백 성분, 탄소 물질, 계면활성제, 지질, 폴리올, 오일, 방부제 및 정제수를 혼합하여, 리포좀 화장료 조성물을 제조한 것을 제외하고는, 실시예 8과 동일하게 실시하였다.In the same manner as in Example 8, except that the liposome cosmetic composition was prepared by mixing the whitening component, carbon material, surfactant, lipid, polyol, oil, preservative and purified water according to Table 8 [Unit:% by weight]. conducted.
이때, 표 8에 실시예 8의 조성물의 내용을 함께 기재하였다.At this time, the contents of the composition of Example 8 are also described in Table 8.
실시예 8Example 8 비교예 3Comparative Example 3 비교예 4Comparative Example 4 비교예 5Comparative Example 5
미백성분whitening ingredient 0.010.01 0.010.01 0.010.01 0.010.01
탄소물질carbon material 풀러렌fullerene 0.0060.006 0.0060.006 0.0060.006 0.0060.006
풀러롤fuller roll 0.0040.004 0.0040.004 0.0040.004 0.0040.004
계면활성제Surfactants 0.10.1 0.00020.0002 -- 2.02.0
지질lipids 0.20.2 0.20.2 0.20.2 0.50.5
폴리올polyol 40.040.0 40.040.0 40.040.0 40.040.0
오일oil 0.0010.001 0.0010.001 0.0010.001 0.0010.001
방부제antiseptic 2.02.0 2.02.0 2.02.0 2.02.0
정제수Purified water to. 100to. 100
제조 6 : 성분 포함 여부에 따른 평가Manufacture 6: Evaluation according to ingredient inclusion
표 9[단위 : 중량%]에 따르도록 미백 성분, 탄소 물질, 계면활성제, 지질, 폴리올, 오일, 방부제 및 정제수를 혼합하여, 리포좀 화장료 조성물을 제조한 것을 제외하고는, 실시예 8과 동일하게 실시하였다.In the same manner as in Example 8, except that the liposome cosmetic composition was prepared by mixing the whitening component, carbon material, surfactant, lipid, polyol, oil, preservative and purified water according to Table 9 [Unit:% by weight]. conducted.
이때, 표 9에 실시예 8의 조성물의 내용을 함께 기재하였다.At this time, the contents of the composition of Example 8 were also described in Table 9.
실시예 8Example 8 비교예 6Comparative Example 6 비교예 7Comparative Example 7 비교예 8Comparative Example 8 비교예 9Comparative Example 9 비교예 10Comparative Example 10 비교예 11Comparative Example 11 비교예 12Comparative Example 12
미백성분whitening ingredient 0.010.01 0.010.01 -- 0.010.01 -- -- 0.010.01 0.010.01
탄소물질carbon material 풀러렌fullerene 0.0060.006 -- 0.0060.006 -- 0.0060.006 -- 0.010.01 --
풀러롤fuller roll 0.0040.004 -- 0.0040.004 -- 0.0040.004 -- -- 0.010.01
계면활성제Surfactants 0.10.1 0.10.1 0.10.1 0.10.1 0.10.1 0.10.1 -- --
지질lipids 1.01.0 1.01.0 1.01.0 -- -- 1.01.0 1.01.0 1.01.0
폴리올polyol 40.040.0 40.040.0 40.040.0 40.040.0 40.040.0 40.040.0 40.040.0 40.040.0
오일oil 0.0010.001 0.0010.001 0.0010.001 0.0010.001 0.0010.001 0.0010.001 0.0010.001 0.0010.001
방부제antiseptic 2.02.0 2.02.0 2.02.0 2.02.0 2.02.0 2.02.0 2.02.0 2.02.0
정제수Purified water to. 100to. 100
[ 실험예 ][Experimental example]
실험예 2 : 물성 평가Experimental Example 2: Evaluation of physical properties
상기 실시예 및 비교예에 따르는 조성물에서, 리포좀의 입자 크기 및 탄성 수치를 평가하고, 그 결과를 표 10에 나타내었다.In the compositions according to the above Examples and Comparative Examples, the particle size and elasticity values of the liposomes were evaluated, and the results are shown in Table 10.
하기의 가변형성 실험에 따라, 리포좀의 입자 크기(단위 : nm) 및 탄성 수치를 평가하였다.According to the following variability test, the particle size (unit: nm) and elasticity of the liposomes were evaluated.
구체적으로, mini extruder로 탄성 리포좀이 인공 투과장벽을 통과하는 정도를 측정하였다. 더 상세히, 탄성 리포좀에 0.2 MPa 의 압력을 1 분 30초 동안 가한후, 0.08 ㎛ 크기의 기공을 가지는 Polycarbonate membrane 을 통과하여 나온 탄성 리포좀의 양을 측정하고, 이를 통과한 리포좀의 입자 크기를 측정하였다.Specifically, the ability of the elastic liposome to pass through the artificial permeability barrier was measured using a mini extruder. In more detail, after applying a pressure of 0.2 MPa to the elastic liposome for 1 minute and 30 seconds, the amount of elastic liposome passing through a polycarbonate membrane having pores of 0.08 μm was measured, and the particle size of the liposome passing through it was measured. .
이때, 탄성 리포좀 막의 탄성은 하기 식에 비례한다.At this time, the elasticity of the elastic liposome membrane is proportional to the following formula.
[식 1 ] Deformability index = JFlux X (rv/rp)2[Equation 1] Deformability index = JFlux X (rv/rp)2
- JFlux : membrane을 통과한 탄성 리포좀의 양- JFlux: The amount of elastic liposomes passing through the membrane
- rv : extrusion 후 리포좀의 입자 크기- rv: Liposome particle size after extrusion
- rp : membrane의 기공 크기- rp: pore size of membrane
또한, 표 10에서 '-'는 리포좀의 불균일 및 불안정한 상태로 인해, 입자 크기의 측정 자체가 어려운 상태를 의미한다.In addition, '-' in Table 10 means a state in which it is difficult to measure the particle size itself due to the non-uniform and unstable state of the liposome.
입자 크기particle size 탄성 수치elastic figure 입자 크기particle size 탄성 수치elastic figure
실시예 8Example 8 257257 23.123.1 비교예 7Comparative Example 7 245245 22.922.9
실시예 9Example 9 232232 18.118.1 비교예 8Comparative Example 8 -- --
실시예 10Example 10 236236 18.218.2 비교예 9Comparative Example 9 -- --
실시예 11Example 11 271271 17.217.2 비교예 10Comparative Example 10 224224 8.98.9
비교예 2Comparative Example 2 -- -- 비교예 11Comparative Example 11 -- --
비교예 3Comparative Example 3 248248 14.814.8 비교예 12Comparative Example 12 -- --
비교예 4Comparative Example 4 263263 12.612.6
비교예 5Comparative Example 5 -- --
비교예 6Comparative Example 6 220220 8.58.5
표 10을 보면, 본 실시예에 따르는 경우, 입자 크기가 적정 수준으로 형성되며, 탄성 수치가 우수함을 알 수 있다.Looking at Table 10, it can be seen that according to the present embodiment, the particle size is formed at an appropriate level and the elasticity value is excellent.
실험예 3 : 안정성 평가Experimental Example 3: Stability evaluation
상기 실시예 및 비교예에 따르는 조성물에서, 리포좀의 안정성을 평가하고, 그 결과를 표 11에 나타내었다.In the compositions according to the above Examples and Comparative Examples, stability of liposomes was evaluated, and the results are shown in Table 11.
구체적으로, 리포좀의 안정성은 상기 실험예 2에 따라, 1 주 마다 리포좀의 입자 크기를 측정하여, 4 주 동안 관찰하면서, 하기 항목에 따라 평가한 결과를 기재한 것이다.Specifically, the stability of the liposome was evaluated according to the following items while observing for 4 weeks by measuring the particle size of the liposome every week according to Experimental Example 2 described above.
*'○' : 약 4 주가 지나는 시점까지 입자 크기의 변화가 거의 없고, 균일하*'○': There is almost no change in particle size until about 4 weeks pass, and it is uniform
게 유지되는 상태state of being maintained
* '△' : 약 2 주차 부터, 입자 크기가 변화하여, 불균일한 상태* '△': From about the 2nd week, the particle size changes and becomes non-uniform
* '-': 불균일 및 불안정한 상태로 인해, 입자 크기의 측정 자체가 어려워, 리포좀 안정도의 평가 자체가 어려운 상태* '-': Due to the non-uniformity and unstable state, it is difficult to measure the particle size itself, and it is difficult to evaluate the stability of the liposome itself.
리포좀 안정도Liposome stability 리포좀 안정도Liposome stability
실시예 8Example 8 비교예 7Comparative Example 7
실시예 9Example 9 비교예 8Comparative Example 8 --
실시예 10Example 10 비교예 9Comparative Example 9 --
실시예 11Example 11 비교예 10Comparative Example 10
비교예 2Comparative Example 2 -- 비교예 11Comparative Example 11 --
비교예 3Comparative Example 3 비교예 12Comparative Example 12 --
비교예 4Comparative Example 4
비교예 5Comparative Example 5 --
비교예 6Comparative Example 6
상기 실험에서 비교예 9의 경우에는 리포좀이 안정적으로 분산되지 않았다.In the case of Comparative Example 9 in the above experiment, the liposome was not stably dispersed.
즉, 본 실시예에 따를 경우에, 리포좀이 안정적으로 균일하게 분산되며, 탄소 물질의 석출이 없어, 우수한 리포좀 안정성을 구현할 수 있음을 의미한다.That is, according to this embodiment, liposomes are stably and uniformly dispersed, and there is no precipitation of carbon materials, which means that excellent liposome stability can be realized.
실험예 4 : 피부 침투율 평가Experimental Example 4: Evaluation of skin penetration rate
상기 실시예 및 비교예에 따르는 조성물에서 나이아신아마이드의 피부 침투율을 측정한 후, 그 결과를 표 12 [단위 : %]에 나타내었다.After measuring the skin penetration rate of niacinamide in the compositions according to the above Examples and Comparative Examples, the results are shown in Table 12 [Unit: %].
구체적으로, 피부 침투율은 경피 흡수 확산 실험(Franz diffusion cell)을 수행하여 평가되었다.Specifically, the skin penetration rate was evaluated by performing a transdermal absorption diffusion experiment (Franz diffusion cell).
먼저, 화장료 조성물이 침적된 피부(면적 : 0.6362 cm2)를 가위로 절삭한 후, 100 % 메탄올 5 mL를 넣고, 초음파 파쇄기로 5 분간 파쇄를 실시한 다음, 이를 0.45μm 필터로 여과한 용액의, 나이아신아마이드 함량을 HPLC로 측정하였다.First, after cutting the skin (area: 0.6362 cm 2 ) on which the cosmetic composition was deposited with scissors, 5 mL of 100% methanol was added, and crushed for 5 minutes with an ultrasonic disruptor, and then filtered through a 0.45 μm filter. Niacinamide content was determined by HPLC.
이 후, 피부침투율(%)을 '피부침투율(%) = (피부에서 측정된 나이아신아마이드 함량 / 침적된 크림에 함유된 나이아신아마이드 함량) X 100(%)'으로 계산한 뒤, 그 결과를 표 12에 나타내었다.After that, the skin penetration rate (%) was calculated as 'skin penetration rate (%) = (niacinamide content measured in the skin / niacinamide content contained in the deposited cream) X 100 (%)', and the results are shown in the table 12.
나이아신아마이드의 피부 침투율(%)Niacinamide skin penetration rate (%) 나이아신아마이드의 피부 침투율(%)Niacinamide skin penetration rate (%)
실시예 8Example 8 44.644.6 비교예 7Comparative Example 7 --
실시예 9Example 9 29.129.1 비교예 8Comparative Example 8 10.210.2
실시예 10Example 10 23.523.5 비교예 9Comparative Example 9 --
실시예 11Example 11 26.226.2 비교예 10Comparative Example 10 --
비교예 2Comparative Example 2 -- 비교예 11Comparative Example 11 --
비교예 3Comparative Example 3 16.216.2 비교예 12Comparative Example 12 --
비교예 4Comparative Example 4 10.310.3
비교예 5Comparative Example 5 --
비교예 6Comparative Example 6 19.319.3
표 12를 보면, 본 실시예에 따를 경우, 유효 성분의 피부 침투율이 현저히 우수함을 알 수 있다.Looking at Table 12, it can be seen that according to this example, the skin penetration rate of the active ingredient is remarkably excellent.
실험예 5 : 주름 및 미백 개선 효과 평가Experimental Example 5: Evaluation of wrinkle and whitening improvement effect
실시예 8 내지 10 및 비교예 6 내지 10의 조성물의 미백 및 주름 개선 효능을 평가하고, 그 결과를 표 13[단위 : 점수]에 나타내었다.The whitening and wrinkle improvement efficacies of the compositions of Examples 8 to 10 and Comparative Examples 6 to 10 were evaluated, and the results are shown in Table 13 [Unit: score].
또한, 대조군으로 폴리올 40 중량%, 방부제 2 중량% 및 잔량의 정제수가 혼합된 화장료 조성물(리포좀 X)을 사용하였다.In addition, as a control, a cosmetic composition (liposome X) in which 40% by weight of polyol, 2% by weight of preservative, and the remaining amount of purified water was mixed was used.
이때, 실험은 총 30 명으로 구성된 그룹(대상 : 20 ~ 30 대 여성)에, 아침 및 저녁으로, 총 4 주 동안 눈가를 포함하는 얼굴 피부에 실시예 8의 리포좀 화장료 조성물을 도포하도록 한 뒤, 미백 및 주름 개선의 정도를 하기 점수로 평가하도록 하여, 그 평균값을 표 13에 나타내었다. 또한, 상기 실시예 8과 동일하게 이외 실시예, 비교예 및 대조군을 이용한 실험을 실시하여, 그 결과를 표 13에 나타내었다.At this time, in the experiment, a group of 30 people (subject: women in their 20s and 30s) were asked to apply the liposome cosmetic composition of Example 8 to the facial skin including the eye area morning and evening for a total of 4 weeks, then, The degree of whitening and wrinkle improvement was evaluated by the following scores, and the average values are shown in Table 13. In addition, in the same manner as in Example 8, experiments using other Examples, Comparative Examples and Controls were conducted, and the results are shown in Table 13.
- 5 점 : 매우 우수- 5 points: very good
- 4 점 : 우수- 4 points: excellent
- 3 점 : 보통- 3 points: Fair
- 2 점 : 나쁨- 2 points: Poor
- 1 점 : 매우 나쁨- 1 point: very bad
미백 평가whitening evaluation 주름 개선 평가Wrinkle improvement evaluation
실시예 8Example 8 4.854.85 4.754.75
실시예 9Example 9 4.204.20 3.913.91
실시예 10Example 10 4.104.10 3.983.98
실시예 11Example 11 4.554.55 4.054.05
비교예 2Comparative Example 2 3.013.01 2.892.89
비교예 3Comparative Example 3 3.003.00 2.872.87
비교예 4Comparative Example 4 2.952.95 2.752.75
비교예 5Comparative Example 5 3.243.24 3.053.05
비교예 6Comparative Example 6 3.343.34 3.013.01
비교예 7Comparative Example 7 3.213.21 3.203.20
비교예 8Comparative Example 8 3.423.42 3.023.02
비교예 9Comparative Example 9 3.123.12 3.243.24
비교예 10Comparative Example 10 2.982.98 2.882.88
비교예 11Comparative Example 11 2.902.90 2.822.82
비교예 12Comparative Example 12 2.902.90 2.812.81
대조군control group 2.882.88 2.782.78
표 13을 보면, 본 실시예에 따를 경우, 미백 및 주름 개선 효과가 현저히 우수함을 알 수 있다.Looking at Table 13, it can be seen that according to the present embodiment, the whitening and wrinkle improvement effects are remarkably excellent.
한편, 미백 성분과 탄소 물질을 포함하지 않는 비교예 10과 대조군을 통해, 기본 화장료 성분(폴리올)과 리포좀 원료는 미백과 주름 개선에는 별다른 영향이 없음을 확인하였다.On the other hand, through Comparative Example 10 and the control group, which did not contain a whitening component and a carbon material, it was confirmed that the basic cosmetic component (polyol) and the liposome raw material had no significant effect on whitening and wrinkle improvement.
[ 제조예 ][Production Example]
제조 7 : 탄소 물질 함량 변화에 리포좀 내 탄소 물질 포집률 평가Manufacture 7: Evaluation of carbon material capture rate in liposomes in response to carbon material content changes
표 14에 따라, 탄소 물질을 포함하는 리포좀 화장료 조성물을 제조하였다.According to Table 14, a liposome cosmetic composition containing a carbon material was prepared.
이때, 표 14에서 탄소 물질은 풀러렌 및 풀러롤이 1.5 : 1의 중량비로 혼합된 것을 사용하였다.At this time, as the carbon material in Table 14, a mixture of fullerene and fullerol at a weight ratio of 1.5:1 was used.
실시예 12Example 12 비교예 13Comparative Example 13
미백성분whitening ingredient 0.50.5 0.50.5
탄소물질carbon material 0.50.5 0.50.5
계면활성제Surfactants 0.10.1 --
지질lipids 1.01.0 1.01.0
폴리올polyol 40.040.0 40.040.0
오일oil 0.0010.001 0.0010.001
방부제antiseptic 2.02.0 2.02.0
정제수Purified water to 100to 100
[ 실험예 ][Experimental example]
실험예 6 : 리포좀 내 탄소 물질 포집률 평가Experimental Example 6: Evaluation of carbon material capture rate in liposomes
상기 실시예 12 및 비교예 13의 리포좀 화장료 조성물에서, 탄소 물질의 포집율을 평가하고, 그 결과를 표 15[단위 : %]에 나타내었다.In the liposome cosmetic compositions of Example 12 and Comparative Example 13, the collection rate of carbon materials was evaluated, and the results are shown in Table 15 [Unit: %].
이때, 탄소 물질의 포집율은, 상기 실험예 1의 나이아신아마이드 포집율과 동일한 방법으로 실시되었다.At this time, the capture rate of the carbon material was carried out in the same manner as the capture rate of niacinamide in Experimental Example 1.
포집율(%)Capture rate (%) 포집율(%)Capture rate (%)
실시예 12Example 12 100100 비교예 13Comparative Example 13 7575
표 14 및 15를 보면, 본 실시예에 따를 경우, 리포좀 내에 탄소 물질이 모두 포집됨을 알 수 있다.Looking at Tables 14 and 15, it can be seen that according to the present embodiment, all carbon materials are trapped in the liposome.
반면, 본 실시예에 따르지 않을 경우에는, 리포좀 내에 포집되지 않고, 잔류하는 탄소 물질이 증가됨을 알 수 있다. 즉, 본 실시예에 따르지 않을 경우에는, 탄소 물질이 피부에 효과적으로 흡수되지 못함에 따라, 피부 개선 효과가 충분하지 못할 수 있다.On the other hand, in the case not according to this embodiment, it can be seen that the remaining carbon material is increased without being trapped in the liposome. That is, when the present embodiment is not followed, as the carbon material is not effectively absorbed into the skin, the skin improvement effect may not be sufficient.
결과적으로, 상기 내용을 종합하여 볼 때, 본 실시예에 따르면, 미백 성분 및 탄소 물질의 포집력이 우수하면서도 적정 크기로 형성되어 안정적인 상태의 리포좀 화장료 조성물을 제공할 수 있다. 이에 따라, 리포좀 화장료 조성물의 미백 및 주름 개선 효과는 현저히 우수할 수 있다.As a result, in view of the above information, according to this embodiment, it is possible to provide a liposome cosmetic composition in a stable state by being formed in an appropriate size while having excellent trapping power of whitening ingredients and carbon materials. Accordingly, the whitening and anti-wrinkle effect of the liposome cosmetic composition may be remarkably excellent.
전술한 바와 같이, 본 발명의 설명은 예시를 위한 것이며, 본 발명이 속하는 기술분야의 통상의 기술을 가진 자는 본 발명의 기술적 사상이나 필수적인 특징을 변경하지 않고서 다른 구체적인 형태로 쉽게 변형이 가능하다는 것을 이해할 수 있을 것이다. 그러므로, 이상에서 기술한 실시예들은 모든 면에서 예시적인 것이며, 한정적이 아닌 것으로 이해해야만 한다. 예를 들어, 단일형으로 설명되어 있는 각 구성 요소는 분산되어 실시될 수도 있으며, 마찬가지로 분산된 것으로 설명되어 있는 구성 요소들도 결합된 형태로 실시될 수 있다.As described above, the description of the present invention is for illustrative purposes, and those skilled in the art to which the present invention pertains can easily be modified into other specific forms without changing the technical spirit or essential features of the present invention. You will understand. Therefore, the embodiments described above are illustrative in all respects, and should be understood as non-limiting. For example, each component described as a single type may be implemented in a distributed manner, and similarly, components described as distributed may be implemented in a combined form.
본 발명의 범위는 상기 상세한 설명보다는 후술하는 특허청구범위에 의하여 나타내어지며, 특허청구범위의 의미 및 범위 그리고 그 균등 개념으로부터 도출되는 모든 변경 또는 변형된 형태가 본 발명의 범위에 포함되는 것으로 해석되어야 한다.The scope of the present invention is indicated by the following claims rather than the detailed description above, and all changes or modifications derived from the meaning and scope of the claims and equivalent concepts should be construed as being included in the scope of the present invention. do.

Claims (9)

  1. 생리활성물질;bioactive substances;
    풀러렌(Fullerene) 및 풀러롤(Fullerol)로 이루어진 군에서 선택되는 하나 이상을 포함하는 탄소 물질;A carbon material containing at least one selected from the group consisting of fullerene and fullerol;
    계면활성제; 및Surfactants; and
    지질;을 포함하는 리포좀을 포함하는 화장료 조성물.A cosmetic composition comprising a liposome comprising a lipid;
  2. 제1항에 있어서,According to claim 1,
    상기 화장료 조성물은 The cosmetic composition
    상기 화장료 조성물 총 중량 기준으로 상기 생리활성물질 0.0001 ~ 1.0 중량%, 상기 탄소 물질 0.001 ~ 3.0 중량%, 상기 계면활성제 0.001 ~ 1.0 중량% 및 상기 지질 0.2 ~ 5 중량%를 포함하는 것인, 화장료 조성물.A cosmetic composition comprising 0.0001 to 1.0% by weight of the bioactive material, 0.001 to 3.0% by weight of the carbon material, 0.001 to 1.0% by weight of the surfactant and 0.2 to 5% by weight of the lipid based on the total weight of the cosmetic composition. .
  3. 제1항에 있어서,According to claim 1,
    상기 화장료 조성물은The cosmetic composition
    상기 생리활성물질 및 상기 탄소 물질을 0.01 ~ 1 : 1 의 중량비로 포함하는 것인, 화장료 조성물.The cosmetic composition comprising the physiologically active material and the carbon material in a weight ratio of 0.01 to 1: 1.
  4. 제1항에 있어서,According to claim 1,
    상기 생리활성물질은 미백 성분, 항산화 성분, 주름 개선 성분, 보습 성분, 항염증 성분, 피부재생 성분, 및 피부노화 억제 성분으로 이루어진 군으로부터 선택되는 어느 하나 이상인 것인, 화장료 조성물.The physiologically active substance is any one or more selected from the group consisting of a whitening component, an antioxidant component, an anti-wrinkle component, a moisturizing component, an anti-inflammatory component, a skin regeneration component, and a skin aging inhibitory component, a cosmetic composition.
  5. 제4항에 있어서,According to claim 4,
    상기 미백 성분은The whitening ingredient
    나이아신아마이드, 아데노신 및 레티노이드계 성분으로 이루어진 군에서 선택되는 하나 이상을 포함하는 것인, 화장료 조성물.A cosmetic composition comprising at least one selected from the group consisting of niacinamide, adenosine, and retinoid-based components.
  6. 제1항에 있어서,According to claim 1,
    상기 계면활성제는The surfactant is
    폴리글리세릴-3메틸글루코오스다이스테아레이트, 글루코리피드, 리조레시친, 소르비탄 스테아레이트, 글리세릴 올레에이트, 글리세릴 스테아레이트, 폴리옥시알킬렌 알킬에테르, 폴리옥시알킬렌 지방산 에스테르, 알킬폴리글루코사이드, 소듐라우릴 에테르 설페이트, 스테아릴 트리메틸 염화암모늄, 알킬폴리글리세릴에테르, 스테아릴트리메틸암모늄 클로라이드, 라우릴트리메틸 암모늄 클로라이드, 디스테아릴디메틸-암모늄 클로라이드, 폴리(N,N'-디메틸-3,5-메틸렌피페리디늄) 클로라이 드, 세틸피리디늄 클로라이드, 알킬테트라암모늄염, 알킬디메틸벤질암모늄염, 알킬이소퀴놀리늄염, 디알킬-모르폴리늄염, 폴리아민 지방산 유도체, 아밀 알코올 지방산 유도체, 벤즈알코늄 클로라이드, 벤즈에토늄 클로라이드 및 포타슘세틸포스페이트로 이루어진 군에서 선택되는 하나 이상을 포함하는 것인, 화장료 조성물.Polyglyceryl-3methylglucose distearate, glucolipid, lysolecithin, sorbitan stearate, glyceryl oleate, glyceryl stearate, polyoxyalkylene alkyl ether, polyoxyalkylene fatty acid ester, alkyl polyglucoside, Sodium lauryl ether sulfate, stearyl trimethyl ammonium chloride, alkyl polyglyceryl ether, stearyl trimethyl ammonium chloride, lauryl trimethyl ammonium chloride, distearyl dimethyl-ammonium chloride, poly(N,N'-dimethyl-3,5 -Methylenepiperidinium) chloride, cetylpyridinium chloride, alkyltetraammonium salt, alkyldimethylbenzylammonium salt, alkylisoquinolinium salt, dialkyl-morpholinium salt, polyamine fatty acid derivative, amyl alcohol fatty acid derivative, benzalkonium chloride , A cosmetic composition comprising at least one selected from the group consisting of benzethonium chloride and potassium cetyl phosphate.
  7. 제1항에 있어서,According to claim 1,
    상기 지질은The lipid is
    대두 레시틴, 난황 레시틴, 하이드로제네이티드 레시틴, 하이드로제네이티드라이소레시틴, 하이드로옥실레이티드 레시틴, 토코페롤, 토코페릴아세테이트, 알루미늄/마그네슘하이드록사이드스테아레이트, 펜타에리스리틸테트라-다이-t-부틸하이드록시하이드로신나메이트 및 카프릭트리글리세라이드로 이루어진 군에서 선택되는 하나 이상을 포함하는 것인, 화장료 조성물.Soy Lecithin, Egg Yolk Lecithin, Hydrogenated Lecithin, Hydrogenated Lysolecithin, Hydroxylated Lecithin, Tocopherol, Tocopheryl Acetate, Aluminum/Magnesium Hydroxide Stearate, Pentaerythrityltetra-di-t-butylhydro A cosmetic composition comprising at least one selected from the group consisting of hydroxyhydrocinnamate and capric triglyceride.
  8. 제1항에 있어서,According to claim 1,
    상기 화장료 조성물은The cosmetic composition
    폴리올, 오일, 방부제 및 정제수로 이루어진 군에서 선택되는 하나 이상을 더 포함하는 것인, 화장료 조성물.A cosmetic composition further comprising at least one selected from the group consisting of polyols, oils, preservatives and purified water.
  9. 생리활성물질;bioactive substances;
    풀러렌(Fullerene) 및 풀러롤(Fullerol)로 이루어진 군에서 선택되는 하나 이상을 포함하는 탄소 물질;A carbon material containing at least one selected from the group consisting of fullerene and fullerol;
    계면활성제; 및Surfactants; and
    지질;을 포함하는 리포좀을 포함하는 피부외용제 조성물.A composition for external application for skin comprising a liposome comprising a lipid.
PCT/KR2022/012309 2021-09-03 2022-08-18 Liposomal cosmetic composition with excellent capture performance of effective component WO2023033414A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2021-0117833 2021-09-03
KR1020210117833A KR102378946B1 (en) 2021-09-03 2021-09-03 Liposome cosmetic compositon with excellent capture performance of effective compotent

Publications (1)

Publication Number Publication Date
WO2023033414A1 true WO2023033414A1 (en) 2023-03-09

Family

ID=80997039

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2022/012309 WO2023033414A1 (en) 2021-09-03 2022-08-18 Liposomal cosmetic composition with excellent capture performance of effective component

Country Status (2)

Country Link
KR (1) KR102378946B1 (en)
WO (1) WO2023033414A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102378946B1 (en) * 2021-09-03 2022-03-28 한국콜마주식회사 Liposome cosmetic compositon with excellent capture performance of effective compotent

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20180003356A (en) * 2016-06-30 2018-01-09 주식회사 씨앤피코스메틱스 Cosmetic composition comprising retinal liposome
KR20180062776A (en) * 2016-12-01 2018-06-11 정준원 Cosmetic composition comprising liposome
CN110946796A (en) * 2019-12-23 2020-04-03 苏州绿叶日用品有限公司 Whitening composition containing endothelin antagonist and preparation method and application thereof
KR102164218B1 (en) * 2019-09-24 2020-10-12 코스맥스 주식회사 Multilayer cationic liposome for enhancing the skin penetration and preparation method thereof
KR102378946B1 (en) * 2021-09-03 2022-03-28 한국콜마주식회사 Liposome cosmetic compositon with excellent capture performance of effective compotent

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100758960B1 (en) 2007-01-09 2007-09-14 오광석 Cosmetic composition containing diospyros kaki fruit extract stabilized with nanoliposome

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20180003356A (en) * 2016-06-30 2018-01-09 주식회사 씨앤피코스메틱스 Cosmetic composition comprising retinal liposome
KR20180062776A (en) * 2016-12-01 2018-06-11 정준원 Cosmetic composition comprising liposome
KR102164218B1 (en) * 2019-09-24 2020-10-12 코스맥스 주식회사 Multilayer cationic liposome for enhancing the skin penetration and preparation method thereof
CN110946796A (en) * 2019-12-23 2020-04-03 苏州绿叶日用品有限公司 Whitening composition containing endothelin antagonist and preparation method and application thereof
KR102378946B1 (en) * 2021-09-03 2022-03-28 한국콜마주식회사 Liposome cosmetic compositon with excellent capture performance of effective compotent

Also Published As

Publication number Publication date
KR102378946B1 (en) 2022-03-28

Similar Documents

Publication Publication Date Title
WO2013039350A2 (en) Skin composition for external use containing ceramides
WO2010016686A2 (en) Nanoemulsion for local administration
WO2014129779A1 (en) Composition externally used for subacid skin and cosmetic material including same
WO2021029541A1 (en) Elastic liposome composition comprising sucrose-based surfactant and cosmetic composition containing same
WO2016200190A1 (en) Cosmetic composition for wrinkle reduction containing gypenoside isolated from gynostemma pentaphyllum
WO2021112398A1 (en) Composition comprising vitamin c
WO2020040442A1 (en) Soothing cream and preparation method therefor
WO2020204293A1 (en) Uv-blocking cosmetic composition
WO2019103433A1 (en) Novel pseudoceramide compound with improved stability and composition comprising same
WO2023033414A1 (en) Liposomal cosmetic composition with excellent capture performance of effective component
WO2021034150A1 (en) Cosmetic composition comprising eutectic mixture
WO2017146414A1 (en) Composition for skin moisturization and skin wrinkle alleviation, containing α-terpineol as active ingredient
WO2018124572A1 (en) Silicon resin composition, preparation method therefor, and scar treatment agent including same
WO2021054773A1 (en) Cosmetic composition with multiple emulsion formulation for active ingredient stabilization and skin absorption acceleration
WO2019093608A1 (en) Pharmaceutical or cosmetic composition for preventing or treating hair loss or promoting hair growth
WO2020218669A1 (en) Facial mask composition having improved moisturizing effect
WO2019013396A1 (en) Cosmetic composition containing hippophae rhamnoides fruit extract for whitening emulsion and method for manufacturing same
WO2019059580A1 (en) High internal phase water-in-oil type cosmetic composition
WO2024063540A1 (en) Multi-layer phase cosmetic composition
WO2012173382A2 (en) Skin composition for external use containing tanshinone ii a as active ingredient
WO2020218670A1 (en) Mask pack composition having improved wrinkle-reducing strength
WO2018066914A1 (en) Tripeptide having fatty acids bonded thereto, and anti-wrinkle cosmetic composition comprising same
WO2020096379A1 (en) Hypoallergenic composition for skin regeneration or skin soothing, containing culture product or extract of aureobasidium pullulans strain
WO2012173383A2 (en) Skin composition for external use containing cryptotanshinone as active ingredient
WO2017119728A1 (en) Cosmetic composition having shape memory ability

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 22864918

Country of ref document: EP

Kind code of ref document: A1